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ABSTRACT
TRANSCRIPTIONAL ELONGATION DEFECTS ENHANCE UPSTREAM POLY (A)
SITE UTILIZATION AND SPT5 AFFECTS mRNA DEGRADATION THROUGH ITS
PHYSICAL AND FUNCTIONAL INTERACTION WITH CCR4-NOT COMPLEX
by
Yajun Cui
University o f New Hampshire, May 2003

While a number of proteins are involved in elongational processes, the
mechanism o f action o f most o f these factors remains unclear primarily because o f the
lack o f suitable in vivo model systems. We have identified in yeast several genes, each
o f which contain internal poly (A) sites, whose full-length mRNA formation is reduced
by mutations in RNA polymerase II subunit RPB2, elongation factor SPT5, or TFIIS.
RPB2 and SPT5 defects also promoted the utilization o f upstream poly (A) sites foT genes
that contain multiple 3’ poly (A) signaling sequences, supporting a role for elongation in
differential poly (A) site choice. Our data suggest that elongation defects cause increased
transcriptional pausing or arrest that results in increased utilization o f internal or
upstream poly (A) sites. Transcriptional pausing/arrest can, therefore, be visualized in
vivo if a gene contains internal poly (A) sites, allowing biochemical and genetic study o f
the elongation process.
The CCR4-NOT complex has been shown to have role in transcriptional
initiation, elongation, and mRNA degradation with the primary role o f CCR4 and CAF1
in the deadenylation and degradation of mRNA. Previous work in our lab has identified a
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physical connection between the CCR4-NOT complex and SPT5. The role of SPT5 in
mRNA degradation was examined. Mutation in SPT5 or an spt4 deletion slowed the rate
o f mRNA degradation, a phenotype associated with defects in the CCR4 and CAF1
mRNA deadenylase complex. Moreover, like ccr4 and cafl deletion, spt5 and spt4
defects affected the rate of deadenylation, but not that of decapping or 5’-3’ degradation
of mRNA. Re-examination of SPT5 location in the yeast cell confirmed that SPT5 is
primarily nuclear but some SPT5 was also found to locate to the cytoplasm. These results
support a role for SPT5/SPT4 in mRNA degradation through inhibition o f CCR4
deadenylase activity.
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GENERAL INTRODUCTION

Gene expression is a complex biochemical process that is governed by the
concerted action of a diverse collection o f regulatory factors. These process can be
divided into synthesis of pre-mature mRNA, modification of pre-mRNA, export of
mature mRNA from the nucleus to the cytoplasm, translation of mRNA into protein and,
finally, degradation of mRNA. At this time, many genome sequencing projects have been
completed and the number o f genes for several organisms have been quantitated. E.coli,
for instance, has more than 5000 genes; Yeast has more than 6000 genes. Drosophila has
about 13,500 genes and our human cells are estimated to contain about 30,000 genes. The
response o f cells to physiological and environmental stimuli requires tight regulation o f
their gene expression, for the multicellular organism, the remarkable diversity in cell
specialization is achieved by precisely controlling when and to what extent genes are
expressed. In humans, many diseases result from mutations that affect various aspects o f
mRNA metabolism, including pre-mRNA processing, export, stability, and translational
control. Understanding how gene expression is regulated is therefore very important to
comprehending biological processes.

The Regulation of Gene Transcription
The first step of gene expression is the synthesis of mRNA, a process termed
transcription. Most eucaryotic genes are transcribed by RNA polymerase II (RNA pol II),
also known as RNA polymerase B (RPB). Yeast RNA pol II is composed of 12 subunits
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encoded by the RPB1 to RPB12 genes (Kolodziej et al., 1990). The two largest RNA pol
II subunits, RPB1 (-200 kDa) and RPB2 (-150 kDa), are the most highly conserved
subunits o f this complex and encode proteins that are orthologs o f bacterial RNA
polymerases.
The first event of transcription is the binding of RNA pol II to the promoter
region o f a gene. Eucaryotic promoters include two independent regulatory DNA
sequences, named core elements and regulatory elements. Core elements define the site
for recruiting RNA pol II and some general transcription factors. Regulatory elements are
gene-specific sequences that are located upstream o f the core promoter and control the
rate o f transcription initiation. General transcription factors, including TBP, TFI03,
TFDE, TFEDF, and TFIIH, are required for RNA pol II to bind to core promoter elements
and initiate transcription accurately (Roeder, 1996). The first transcription factor to
associate with the promoter region during transcription initiation is TBP which
recognizes the TATA element in the core promoter. After TBP and its associated factors
bind, TFDOB will associate with TBP to stabilize the TATA-TBP interaction and recruit
RNA pol II and other general transcription factors (Orphanides et al., 1996; Roeder,
1996).
Many factors play roles in the regulation of transcription initiation. Some proteins
can directly bind to the DNA regulatory elements to control the rate o f transcription
initiation. Other proteins regulate initiation positively or negatively by interaction either
with general transcription factors (TFIIA, TBP-Associated Factors (TAFs), CCR4/NOT
etc..) or with nucleosomes (SWI/SNF, Histone Acetyltransferase (HAT), SPT5/SPT4
etc.).

2
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Following transcription initiation, RNA pol II moves away from the promoter
region and dissociates from some o f the general transcription factors after synthesizing a
10 to 15 nucleotide-long transcript. This is called promoter escape. Biochemical studies
have shown that during early elongation and promoter escape the transcripts less than
approximately 9 nucleotide-long are unstable and RNA polymerase is prone to aborting
transcription (Holstege et al., 1997; Keene and Luse, 1999). Transcription factor TFIIF
can decrease the frequency o f abortive transcription, and TFEDE and TFIIH can also help
RNA pol II to overcome some transcription difficulties during promoter escape (Dvir et
al., 1997; Kugel and Goodrich, 1998; Kumar et al., 1998; Yan et al., 1999). After RNA
pol II leaves the promoter region, mRNA will continue to be synthesized along the DNA
template. This step is called elongation. During transcriptional elongation, addition o f the
next nucleotide to a growing RNA chain by RNA pol II requires that the 3’-OH terminus
o f the nascent transcript be precisely aligned with the DNA template and with the
catalytic site of pol II for nucleotide addition. Pausing can occur when RNA pol II
undergoes modest and reversible backsliding on the DNA template. RNA pol n retains
the ability to restart synthesis without the aid o f additional factors. Arrest occurs with
essentially irreversible backsliding o f the RNA pol n. Ancillary factors are required to
release RNA pol II from arrest, one o f which is elongation factor IIS that enables pol II to
be reactivated from transcriptional arrest by activation of nascent RNA cleavage (Wind
and Reines, 2000).
Recently, a number of factors have been identified as either components of the
elongating polymerase or as possible modulators o f the process o f elongation. For
instance, DSDF and its yeast orthologs SPT4 and SPT5 possibly regulate elongation
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through interactions with hypophosphorylated RNA polymerase (Hartzog et al., 1998;
Wada et al., 1998b; Wada et al., 1998c; Yamaguchi et al., 1999a). RPB1, -2, -5, -6 and -9
are components of the RNA polymerase II enzyme and make contact with the DNA that
would be important to the elongation process (Cramer et al., 2000; Hemming et al., 2000;
Powell and Reines, 1996). In addition, a vast amount of genetic evidence has implicated
these and other factors such as the recombination important protein HPR1 (Chavez and
Aguilera, 1997; Chavez et al., 2001) and components o f the CCR4-NOT complex (Denis
et al., 2001) in controlling elongation.
The last phase o f transcription is termination/3’ end formation. Upon reaching the
relatively ill-defined termination signals at the end o f a gene, the nascent RNA is cleaved
and the poly (A) tail is added to the 3’ end o f RNA. The RNA transcript is released from
RNA pol II and RNA pol II is dissociated from the DNA template. Sequence elements in
the 3’ untranslated region (3’-UTR) o f pre-mRNAs specify the site at which adenosines
are added (termed poly (A) site). The mammalian 3’-end formation complex selects the
poly (A) sites through recognition of the conserved upstream AAUAAA sequence and a
degenerate downstream element. In contrast to higher eukaryotes, the yeast
Saccharomyces cerevisiae uses degenerate and complex signals to direct the 3’-end
formation. At least three elements are needed to make up a minimal yeast mRNA 3’-end:
the UA-rich efficiency element; the A-rich positioning that directs the position o f the
cleavage site; and the actual site of polyadenylation (Zhao et al., 1999). RNA pol II
transcription termination, in contrast, is a somewhat random process occurring at sites
between 200-2000 bp downstream of the poly (A) site, although it is dependent upon the
presence o f a functional poly (A) signal (Proudfoot, 1989). On the other hand,
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transcriptional pause sites located downstream o f the poly (A) site are thought to cause a
transient pause to Pol II progression and so enhance poly (A) site recognition (Aranda
and Proudfoot, 1999; Birse et al., 1997; Yonaha and Proudfoot, 1999; Yonaha and
Proudfoot, 2000).

The Regulation of mRNA Degradation
The stability of mRNA is also an important determinant in gene expression.
Regulation o f the rate of mRNA degradation is a major factor in determining the
abundance of cellular mRNA. In eucaryotic cells, the decay rates o f individual mRNAs
vary by more than two orders o f magnitude. Moreover, there are numerous examples o f
mRNA decay rates being regulated in response to various stimuli.
The mature mRNA bears a 5’ cap structure and 3’ poly (A) tail, both o f which
protect the mRNA from degradation. Recent work has demonstrated that at least four
related, yet distinct, pathways allow polyadenylated mRNAs to be degraded in eucaryotic
cells (Beelman and Parker, 1995). In most cases the degradation o f the transcript begins
with the shortening of the poly (A) tail at the 3' end o f the mRNA. A principal mRNAdegradation pathway is initiated by deadenylation (shortening of the poly (A) tail at the
3’-end o f mRNA), which is followed by decapping (removal o f the 5’ cap structure). The
rest o f mRNA is then digested 5’ to 3’ by exonucleases.
Many o f the components required for RNA 3'-end processing have now been
identified and appear to be conserved between yeast and mammals. In yeast, a poly (A)specific ribonucleases (PAN) was identified based on its requirement for the poly (A)
binding protein (PAB1) for activity (Lowell et al., 1992; Sachs and Deardorff, 1992).

5
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

PAN is composed o f at least two subunits, PAN2 and PAN3, and is the first deadenylase
for which the genes encoding the enzymatic activity have been identified (Boeck et al.,
1996; Brown et al., 1996). Recently, the CCR4-NOT complex has been identified as the
major cytoplasmic deadenylase complex (Chen et al., 2002; Daugeron et al., 2001;
Tucker et al., 2002; Tucker et al., 2001). It is suggested that PAN2/PAN3 exonuclease
may play a role in initial trimming o f the nuclear poly (A) tail (Brown and Sachs, 1998).
After the nascent poly (A) tail o f the mRNA is trimmed by the PAN2/PAN3 nuclease, it
is subsequently passed to the CCR4-NOT complex for the majority o f cytoplasmic
deadenylation (Tucker et al., 2001).
The second step o f mRNA degradation is decapping. Genetic and biochemical
studies have shown that the DCP1 protein is the major mRNA decapping enzyme in yeast
(Beelman et al., 1996). Several experiments suggest possible ways in which the activity
o f the decapping enzyme maybe modulated. First, DCP1 can be posttranslationally
modified, which will influence its activity. Second, the polypeptide DCP2 has been
identified as a positive regulator o f the decapping enzyme and suggests that a direct or
indirect interaction of DCP1 with DCP2 is required for production of active decapping
enzyme (Dunckley and Parker, 1999). Finally, the protein chaperone HSP70 may
function as a global regulator of DCP1 activity (Zhang et al., 1999).
The requirement of deadenylation before decapping indicates that the poly (A) tail
also acts as an inhibitor of decapping(Decker and Parker, 1993; Muhlrad et al., 1994;
Muhlrad et al., 1995). Several observations imply that the ability o f the poly (A) tail to
inhibit decapping is mediated through the poly (A) binding protein (PABl) (Caponigro
and Parker, 1995; Morrissey et al., 1999; Sachs et al., 1987). One model is that the
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process of deadenylation can lead to a loss of PABl binding at the 3' end o f the mRNA
and the subsequent activation of decapping.
Cleavage o f capped mRNAs by DCP1 yields the products m7GDP and a 5'monophosphate mRNA. Production o f a transcript with a 5'-monophosphate mRNA is
functionally significant resulting in the rapid degradation by the 5' to 3' exonuclease
X m lp, which degrades mRNA following decapping.
The regulation of gene expression can also happen during pre-mRNA processing,
mRNA transport from nucleus to cytoplasm, and the processes by which information is
transferred from RNA to protein (translation). My project involved understanding how
gene transcription and mRNA degradation are regulated, especially in the identification
o f factors and mechanisms utilized in the control of eucaryotic transcriptional elongation
and mRNA deadenylation.

I: Investigate the Role of Elongation Factors in Transcriptional Elongation in vivo
Recently, in yeast and other organisms, a number of factors have been identified
as either components of the elongation polymerase or as possible modulators o f the
process of elongation. Biochemical and in vitro studies have demonstrated or suggested a
requirement for several of these factors in elongation such as RPB2, SPT5/SPT4, HPR1,
and TFHS.
During the process of elongation, RNA pol II can encounter a variety o f
transcriptional blocks including DNA sequences, DNA bound proteins, DNA binding
drugs, and covalent modifications due to DNA damage. As a result of the RNA pol II
structure being recently determined, it is clear that RPB2 may play multiple roles during
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elongation (Cramer et al., 2000). For instance, N-terminal regions o f RPB1, RPB6, and
C-terminal regions of RPB2 can form a clamp that can be used to bind the DNA templete
near the active site during elongation. RPB1 and RPB2 can also form a funnel for
substrate entry, backtracking, and elongation factor access. In vitro evidence confirms a
key role for RPB2 in elongation. Mutations in the RPB2 gene result in sensitivity to the
drug 6-azauracil (6AU), which reduces intracellular NTP concentrations and thus is
expected to decrease the rate o f transcript elongation. RPB2 mutations also increase
transcriptional arrest at known mammalian pause sites in vitro (Powell and Reines, 1996).
In particular, the mutation in region H o f RPB2 (rpb2-10), a domain highly conserved
among all organisms that is associated with nucleotide binding (Scafe et al., 1990), has
the most severe effect in elongation. Moreover, TFIIS is also required by RNA pol II to
overcome the arrest in elongation that occurs at such sites in vitro (Powell and Reines,
1996) and the rpb2-10 allele in combination with a dstl (encode TFIIS) deletion cause
severe defects in the synthesis of most mRNA in vivo (Lennon et al., 1998), indicating
that in vivo rpb2-10 is actually causing pausing/arrest of RNA pol II during elongation
that requires TFIIS to suppress and overcome.
Suppressor of Ty (SPT) genes were originally identified through a genetic screen
for mutations in the yeast Saccharomyces cerevisiae that restore gene expression
disrupted by the insertion of the transposon Ty (Malone et al., 1993; Swanson et al.,
1991b; Winston and Carlson, 1992; Winston et al., 1984). The SPT genes have been
identified as encoding either histones or proteins that affect chromatin function (Winston,
1992). SPT4 and SPT5, as members of SPT class of genes, were implicated in
transcriptional regulation by affecting chromatin function (Swanson and Winston, 1992).

8
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SPT4 and SPT5 form a complex in yeast and their higher eucaryotic orthologs are
components of the DSIF complex. DSIF and SPT5/SPT4 have been found to be capable
o f both stimulating and repressing pol II elongation. DSIF complex is known to be
important to repressing elongation in vitro and appears to do so by acting together with
negative elongation factor (NELF) and positive transcription elongation factor (P-TEF) b
to regulate the phosphorylation of the C-terminal domain (CTD) o f the pol II largest
subunit (Wada et al., 1998b; Wada et al., 1998c; Yamaguchi et al., 1999a; Yamaguchi et
al., 1999c). Studies on HIV transcription have revealed the possible mechanism
underlying the stimulatory activity o f DSIF. Successful transcription from the HIV LTR
promoter requires the viral transactivator TAT. The absence of TAT results in a strong
block to elongation at around +50 nt from the transcriptional start site. The SPT5 subunit
o f DSIF has been identified as one of the factors that are required for Tat-dependent
transcription and depleting SPT5 in a TAT dependent system promotes pausing and
transcriptional termination, indicating a positive role for SPT5 in elongation (Bourgeois
et al., 2002; Wu-Baer et al., 1998). Moreover, various genetic analyses have also
implicated SPT5 and SPT4 in controlling elongation in vivo. In yeast S. cerevisiae, some
spt4 and spt5 defects elicit a 6-azauracil (6AU) sensitive phenotype (Hartzog et al.,
1998). In addition, certain spt5 alleles can be suppressed by mutations in two o f the
largest subunits of pol II and by elongation factor TFIIS (Hartzog et al., 1998).
HPR1 was originally identified as playing a role in mitotic intrachromosomal
excision recombination (Aguilera and Klein, 1988). Recently, HPR1 has been found to be
the component of an RNA pol II holoenzyme complex involved in elongation and the
component of a multi-subunit complex containing other putative elongation factors
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(Chavez and Aguilera, 1997; Chavez et al., 2000). Moreover, the absence o f HPR1
causes impairment of transcription elongation through the lacZ gene. The intensity of
such a transcriptional impairment depends on the transcribed DNA sequence, and HPR1
is preferentially required for transcription o f either long or G+C-rich DNA sequences in
Saccharomyces cerevisiae (Chavez and Aguilera, 1997; Chavez et al., 2001).
Although these proteins were identified as elongation factors by using genetic
assays and in vitro biochemical studies, their effects on transcriptional elongation in vivo
is not clear. In the yeast Saccharomyces cerevisiae, the principal limitation to
characterizing the action of factors involved in elongation has been the lack o f
identification of specific genes whose expression is affected by defects in these
elongation factors and the lack of the suitable in vivo elongation assay. In this thesis, I
identified several bona fide yeast genes containing naturally occurring internal poly (A)
sites whose elongation is impaired with rph2-10, spt5-4 and dstl defects. An in vivo
transcriptional elongation assay was established and the effect o f these elongation factors
on elongation in vivo was thoroughly examined.

II: Investigate Roles of SPT5/SPT4 in mRNA Degradation And Their
Relationships With The CCR4-NOT Complex
The evolutionarily conserved proteins CCR4/CAF1 belong to the CCR4-NOT
complex. The CCR4-NOT complex exists in two forms, 1.9 MDa and 1.0 MDa in size
(Liu et al., 1997). The smaller complex contains CCR4, CAF1, the five NOT proteins
(NOT 1-5), CAF40 and CAF130 (Chen et a l, 2001; Liu et a l, 1998). CCR4 and CAF1
bind a central section of NOT1 whereas the NOT2-5 proteins bind the C-terminal region
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o f NOT 1. CAF40 and CAF130, whose precise biological functions are not known, bind
other areas of NOT1 (Bai et al., 1999; Chen et al., 2001). The organization o f the CCR4NOT complex, with a distinct CCR4/CAF1 module and a NOT2-NOT5 module,
recapitulates the functional differentiation of these two groups o f proteins. CCR4 and
CAF1, as the major cytoplasmic deadenylase complex, act to control the degradation of
mRNA (Chen et al., 2002; Daugeron et al., 2001; Tucker et al., 2002; Tucker et al.,
2001). NOT4 protein has been found to display ubiquitin-protein ligase activity, which
indicate a role for NOT4 in protein degradation (Albert et al., 2002). NOT1-NOT5
proteins physically interact with TFDD and are presumed to restrict TFHD access at
certain promoters (Badarinarayana et al., 2000; Deluen et al., 2002; Lemaire and Collart,
2000). Genetic studies also indicate a role for CCR4 in transcriptional elongation (Denis
et al., 2001). Moreover, whole genome cDNA microarray analysis using defects o f the
components o f the CCR4-NOT complex showed that, while the CCR4-NOT facters
particularly affected genes involved in stress response, protein degradation, pheromone
response, DNA repair, and carbon metabolism as previously suggested, a number of
newly identified groups of genes appear regulated by CCR4-NOT components (Cui,
Shrivastav and Denis, unpublished results). Consistent with their multiple functions, the
CCR4-NOT proteins have been localized to both nuclear and cytoplasmic compartments
(Tucker et al., 2002; Tucker et al., 2001).
The most well understood biochemical function for the CCR4-NOT complex is its
role as the cytoplasmic mRNA deadenylase. Several pieces o f evidence indicate that
CCR4 is the critical enzymatic component of the major cytoplasmic deadenylase. First,
both ccr4 and ca.fl deletions reduce the rate o f mRNA deadenylation (Tucker et al.,

11
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

2001). Second, purified CCR4 displayed deadenylase activity but CAF1 solely did not
have this activity (Chen et al., 2002; Tucker et al., 2001). Third, overexpression o f CCR4
can suppress the deadenylation defects o f a cafl strain, but CAF1 overeexpression can
not complement a ccr4 defect (Tucker et al., 2002). Finally, mutations in the key,
catalytic residues o f CCR4 can abolish both its in vivo function and its in vitro
deadenylase activity (Chen et al., 2002; Tucker et al., 2002). Although other components
o f CCR4-NOT complex do not have deadenylase activity, several observations indicate
that CCR4-NOT complex as a whole functions as the cytoplasmic mRNA deadenylase.
First, CCR4 and CAF1 are in the same complex with the NOT proteins (Liu et al., 1998).
Second, all components of CCR4-NOT complex are present in the cytoplasm (Tucker et
al., 2002; Tucker et al., 2001). Moreover, deletion of NOTs and CAF1 genes can also
result in deadenylation defects for certain mRNAs. While deleting the NOTs does not
result in as severe effects as ccr4 observed with (Tucker et al., 2002), deleting cafl gives
very similar phenotype and mRNA degradation defects observed with ccr4. These results
suggest that CAF1 is critical for CCR4 deadenylase activity.
Several factors could affect CCR4 deadenylase activity. First, CCR4 deadenylase
activity depends on its RNA substrates. CCR4 prefers RNA with at least 2A residues at
its 3’ end, and reacts better with RNA substrates that are at least 17 nucleotides in length.
In addition, longer RNA substrates (45 nucleotides) convert CCR4 from a slow
distributive enzyme to a fast processive enzyme (Viswanathan et al., 2003). Second, poly
(A) binding protein (PABl) has also been shown to inhibit CCR4 deadenylase activity in
vitro (Tucker et al., 2001).
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Recently, a physical interaction between SPT5 and CCR4-NOT complex was
identified in our lab. First, we found that immunoprecipitation o f SPT5 can coimmunoprecipite multiple CCR4-NOT components. Two-hybrid analysis also confirms
an interaction between SPT5 and the C-terminal region o f CCR4. Second, we have
demonstrated in vitro that purified CAF1, CCR4-C-terminus, and NOT1 can each bind
purified SPT5. Third, CCR4 and CAF1, like SPT5, are known to associate with RPB1,
the largest subunit o f RNA polymerase II (Chang et al., 1999). Moreover, different spt5
alleles display either suppression or exacerbation o f ccr4 defects, suggesting that not only
there is a physical interaction between SPT5 and CCR4-NOT complex, SPT5 also
functionally interact with CCR4-NOT complex.
In this thesis, I examined the effect of SPT5/SPT4 on mRNA degradation and
whether it performs this effect through its physical and functional interaction with the
CCR4-NOT complex.
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CHAPTER I

IDENTIFICATION OF GENES WHOSE FULL-LENGTH EXPRESSION IS
AFFECTED BY DEFECTS IN THE TRANSCRIPTIONAL ELONGATION FACTORS
RPB2, TFHS AND SPT5: IN VIVO EVIDENCE THAT ELONGATIONAL DEFECTS
ENHANCE UPSTREAM POLY (A) SITE UTILIZATION

Abstract
While a number of proteins are involved in elongational processes, the
mechanism o f action o f most of these factors remains unclear primarily because of the
lack o f suitable in vivo model systems. We have identified in yeast several genes, each
o f which contain internal poly (A) sites, whose full-length mRNA formation is reduced
by mutations in RNA polymerase II subunit RPB2 (rpb2-10 that slows the enzyme’s
elongation rate), elongation factor SPT5 (spt5-4), or TFHS (dstl). Genes containing
cryptic poly {A) sites (as found in the E.coli la.eZ gene), internally inserted defective
ADH2 poly (A) signaling sequences, or naturally occurring internal poly (A) sites
(RNA 14, CBP1, and AEP2) are subject to decreased full-length mRNA formation and
enhanced internal poly (A) site utilization as a result o f the rpb2-10, spt5-4 and dstl
alleles. Full-length expression through yeast genes lacking internal poly (A) sites was
unaffected by these alleles. Importantly, the rpb2-7 allele, which does not cause RNA pol
II arrest, had little or no effect on the in vivo full-length expression of genes containing
internal poly (A) sites. rpb2-10 and spt5-4 also promoted the utilization o f upstream poly
(A) sites for genes that contain multiple 3’ poly (A) signaling sequences, suggesting a
role for elongation in differential poly (A) site choice. Our data suggest that defects such
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as rpb2-10, spt5-4 or dstl cause increased transcriptional pausing or arrest that results in
increased deposition of poly (A) cleavage/adenylation factors and hence utilization of
internal or upstream poly (A) sites. Transcriptional pausing/arrest can, therefore, be
amplified and visualized in vivo if a gene contains internal poly (A) sites, allowing
biochemical and genetic study of the elongation process.

Introduction
The regulation of the expression of eucaryotic genes can occur at different and
multiple levels. Control of the elongation phase of transcription has been found to be
important for a number of genes, most notably those in higher eucaryotes (Uptain et al
1997; Conaway et al 2000). It is expected, therefore, that numerous biological controls
would be in place to ensure that elongation occurs to the extent and degree it should to
result in the proper levels of mRNA for the different genes in the cell. Most importantly,
recent evidence has suggested that the elongation process is linked and critical to other
post-transcriptional processes such as mRNA capping, splicing,
polyadenylation/cleavage, and transport (Calvo and Manley 2001; Strasser et al 2002;
Proudfoot et al 2002). Elongation can therefore be viewed as the center through which
the whole quality control o f mRNA formation can be integrated (Maquat and Carmichael
2001; Orphanides and Reinberg 2002; Proudfoot et al 2002).
Recently, in yeast and other organisms, a number o f factors have been identified
as either components of the elongating polymerase or as possible modulators o f the
process of elongation. Biochemical and in vitro studies have demonstrated or suggested a
requirement for several of these factors in elongation. As a result of the RNA pol II
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structure being recently determined, it is clear that the RPB2 subunit o f RNA pol II may
play multiple roles during elongation (Cramer et al 2000). In vitro evidence confirms a
key role for RPB2 in that RNA pol II containing either the rpb2-10 or rpb2-4 proteins
fails to elongate well in vitro (Powell and Reines 1996). In particular, the rpb2-10
protein causes arrest at known mammalian pause sites and requires elongation factor
TFHS for overcoming the arrest that occurs at such sites. Moreover, the rpb2-10 allele in
combination with a dstl (encoding TFHS) deletion causes severe defects in the synthesis
o f most mRNA in vivo (Lennon et al 1998) and reduces the induction o f a number of
other genes (Wind-Rotolo and Reines, 2001). These observations suggest that in vivo
rpb2-10 is actually causing promiscuous arrest o f RNA pol II that requires TFHS to
suppress and overcome.
Another important factor involved in elongation are yeast proteins SPT5/SPT4
whose higher eucaryotic orthologs are components o f the DSIF complex. SPT5/4 have
been found to be both activators and repressors o f elongation. The DSIF complex is
known to be important to repressing elongation in vitro and appears to do so by its
interaction with the hypophosphorylated form o f the RNA polymerase IICTD (Wada et
al 1998a,b; Yamaguchi et al 1999a,b). Drosophila SPT5 in the control of hsp70 is
known to be recruited to the transcribing polymerase, although it also may have a role in
forming the paused RNA pol II complex at hsp70 (Andrulis et al 2000; Kaplan et al
2000). Also, depleting SPT5 in a TAT dependent system promotes pausing and
transcriptional termination, indicating that SPT5 can have positive roles on elongation in
addition to previously described negative roles (Bourgeois et al 2002). Various genetic
analyses have implicated SPT5 and SPT4 in controlling elongation in vivo (Hartzog et al

16
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

1998) and initiation (Swanson and Winston 1992). In addition, certain spt5 alleles can be
suppressed by rpb2-10, or by the presumed slowing of elongation (Hartzog et al 1998).
The physical association of the SPT5/4 complex with RNA pol II further confirms its
importance to RNA pol II function (Hartzog et al 1998).
In the yeast Saccharomyces cerevisiae the principal limitation to characterizing
the action of factors involved in elongation has been the lack o f identification o f specific
genes whose expression is affected by defects in these elongation factors. For instance,
no particular gene whose elongation is affected by these factors has been identified
(Lennon et al 1998; Shaw and Reines 2000; (Wind-Rotolo and Reines, 2001). Similarly,
whole genome microarray analysis with dstl and rpb9 alleles did not yield particular
genes controlled at the level of elongation (Hemming et al 2000). Because many putative
elongation factors also can play roles in affecting initiation (SPT5/4, PAF1 complex,
TFIIE/IIF/IIH, RPB subunits, TFHS, CCR4-NOTs) (Swanson et al 1991; Swanson and
Winston 1992; Tan et al 1995; Conaway et al 2000; Shaw and Reines 2000; Collart and
Struhl 1993; Denis et al 2001; Denis and Maivar 1990), it is paramount to identify genes
in yeast regulated at the level of elongation.
The lacZ gene, albeit an E.coli gene, has been found to be regulated at the level of
elongation when expressed in yeast (Chavez and Aguilera 1997). The hprl deletion
reduces transcription through lacZ apparently because of both its high G-C content and
its extreme length (Chavez et al 2001). We have consequently examined whether other
defects in elongation factors also affected expression through lacZ. Our results show that
defects in SPT5 and RNA polymerase subunit RPB2 impair transcription through the E.
coli lacZ gene but by a different mechanism than found for hprl. We show that
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transcription through genes containing internal polyadenylation sequences is particularly
sensitive to spt5-4 and rpb2-10 defects. Most importantly, we identify several bona fide
yeast genes containing naturally occurring internal poly (A) sites whose elongation is
impaired with rpb2-10, spt5-4 and dstl defects. Our model is that spt5-4, rpb2-10 and
dstl alleles cause pausing or arrest during elongation, resulting in increased deposition of
poly (A) cleavage/adenylation factors at these internal poly (A) sites. These results are
consistent with other studies linking downstream pause sites to poly (A) site utilization
(Aranda and Proudfoot, 1999; Birse et al., 1997; Yonaha and Proudfoot, 1999; Yonaha
and Proudfoot, 2000) and imply that elongational pausing/arrest can be studied
biochemically and genetically in vivo using genes containing internal poly (A) sites.

Material And Methods
Yeast Strains. Growth Conditions And Enzyme Assays
Yeast strains are listed in Table 1. Yeast were grown on YEP medium (1% yeast
extract/2% bactopeptone), minimal medium or CAA-IT medium (Liu et al 1998)
supplemented with an appropriate carbon source as indicated in the Figures. Pgalactosidase activities were determined as described previously (Liu et al 1998).
RNA Analyses
Quantitative SI nuclease protection assays were conducted as described (Collart
and Struhl 1993) using the oligonucleotides listed in Table 2. Control experiments in
each case indicated that at the concentration o f SI nuclease used, no radioactively labeled
oligonucleotide remained if no RNA was present and that the SI nuclease assay was
linear over the concentration o f RNAs used.
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Total RNA and mRNA were purified and Northern blots were conducted as
described previously (Cook and Denis, 1993; Denis et al., 1983). Oligonucleotides were
radiolabelled at their 5’ end with T4 polynucleotide kinase as described (Chen et al.,
2002 ).
For the analysis of the polyadenylated species of GAL1 mRNA, GAL1 gene
expression was induced for 15 minutes by shifting yeast from raffmose-containing
medium to galactose-containing medium. The newly synthesized GAL1 mRNA were
detected using an RNase H assay in which a 18-nt DNA probe (5’GCCATTTGGGCCCCCTGG-3’) complementary to the sequences 133 bp upstream of
the GAL1 translation stop codon was hybridized to total yeast RNA prior to RNase H
cleavage (Tucker et al., 2001). The resultant GAL1 3’ polyadenylated species were
detected by Northern analysis using a probe that was complementary to the 3’ end of
GAL1 (5 ’-GCCCAATGCTGGTTTAGAGACGATGAT
AGCATTTTCTAGCTCAGCATCAGTGATCTTAGGG-3’).
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Table 1
Yeast Strains
Genotype

Strain
FY1642

MATa his4-912Slys2-1288leu2Al ura2-52 SPT5-FLAG

FY1642-la

isogenic to FY1642 except ccr4::URA3

FY1668-UH

MATa his4-912 8 lys2-128Sspt5-4 ura3::HIS3

FY1668-UH

isogenic to FY I668-11H except ccr4::URA3

FY1635

MATahis4-9125lys2-128Sleu2Al ura3-52 spt5-242

L615

MATa his4-9125lys2-128Sura3-52 ade2-l trp5 canl-100 spt5-25

FY300

MATa his4-9125lys2-1286leu2Al ura3-52 spt5-194

GHY180

MATaura3-52 leu2Al his 4-9128 lys2-128Sspt4A2::HIS3

FY276-UT

MATa leu2Al ura3::TRPl his4-9128 lys2-1288spt5-8

AYW3-1B1

MATa leu2 trpl ura3 his3

AYW3-3D1

MATa leu2 his3 ura3 leu2-k::ADE2-URA3-leu2-k hprlA3::HIS3

Z96

MATa ura3-52 Ieu2-3,U2 his3A200 rpbA297::HIS3 \pRP214 (LEU2
RPB2)1

Z96-la

isogenic to Z96 except ccr4::URA3

Z100

isogenic to Z96 except \pKP2-4L (LEJJ2 rpb2-4)\

ZlOO-la

isogenic to FY1642 except ccr4::URA3

Z106

isogenic to Z96 except \pRP2-10L (LEU2 rpb2-10)]

Z106-la

isogenic to FY1642 except ccr4::URA3

Z103

isogenic to Z96 except \pRP2-7L (LEU2 rpb2-7)]

DY106-U

isogenic to Z96 except dstlr.hisG

DY108

isogenic to Z 106 except dstlr.hisG

EGY188

MATa ura3 his3 trpl LexAop-LEU2

EGY188-la

Isogenic to EGY188 except ccr4::URA3
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Table 2. Oligonucleotide probe:
Probe name

Probe number

ADH2
probe

5’ probe

3’ probe
NOT1
probe

5’ probe

3’ probe
YAT1
probe

5’ probe
3’ probe

RNA14
probe

5’ probe

3’ probe
CBP1
probe

5’ probe

3’ probe
AEP2
probe

5’ probe

3’ probe
5’ probe

lacZ
probe

0.5 kb probe
1.5 kb probe
2.3 kb probe
3’ probe

Sequence
5’-GTATTACGATATAGTTAATAG
TTGATAGTTGATTGTATGCTTTTT
GTAGCTTGATATTCTATTTACCA
AGAAGAAAC-3’
5’-GGCATACTTGATAATGAAAAC
TATAAATCGTAAAGACATAAG-3 ’
5 ’-GCGGCCTGTTTTTCCTTTGATG
TTTCTAAATTAGATGCTGTGTTCA
AATCACGGGTCC-3 ’
5 ’-GGCGGATTGGTCATCTTGTTC
ACTGGTTGTGT ATTTTTTGG-3 ’
5 ’-GGCGCTCGTCCTGCAGGGGTT
CCACGCGTGCCAGGTAGCGG-3 ’
5 ’-GCGGTCGATCTCCAGCAGCGA
CTTTTCCATGAGCGACGCAAACC
GAGCAGTCTGGCG-3 ’
5 ’-GGCTCTGCGACTTTGTCCGCA
GAGGGATATAGTAAATCAGGAG
TCGTAGAG-3’
5 ’-GCGCATCGAGTAAATTTGTAT
TAAAATATTGACGTTTTGG-3 ’
5 ’-CCCTGCTGCTGTGGTTGATTCG
TCGCAAGGTCCTGGTAGGTACCA
TTTTTATAAACCTCTCGG-3 ’
5 ’-GCCGTTCATCTTAAGTAACGTT
TGACAGCCGACACACCATGC-3 ’
5 ’-CGGGGATAGACAGAATGAC AT
ATTGTGCTATTCGGCAGTACACC
AAATTCACGCAGCG-3 ’
5’-CCCCGGTTTGAAACTCCTTAA
AACATCAATTCCAAGCGGG-3 ’
5'-GGATCCGGTCATTATTAATTTA
GTGTGTGTATTTGTGTTTGCGTGT
CTATAGAAGTATAGTA-3'
5 ’-GCGCTCAGGTCAAATTCAGAC
GGCAAACGACTGTCCTGGCC-3 ’
5 ’-CGGGAAGGGCTGGTCTTC ATC
CACGCGCGCGTACATCGGGC-3 ’
5 ’-CGCC AATGTCGTTATCCAGCG
GTGCACGGGTGAACTGATCGC-3 ’
5 ’-CCGCGTGCAGCAGATGGCGAT
GGCTGGTTTCCATC AGTTGC-3 ’

Location

-80 - -4

+1126 ~ +1167
+ 1 8 - +71

+6245 - +6285
+ 5 1 -+ 9 1
+1876-+ 1932

+ 5 -+ 5 9

+1927-+ 1966
+32 - +94

+ 1929-+ 1970
+ 8 6 -+ 1 4 3

+ 1 4 0 1 - +1440
-4 9 -+ 1 2

+487 - +527
+ 1502-+1542
+2345 - +2386
+2898 - +2938

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Results
The rpb2-10, rpb2-4, sot5-4. And spt4 Alleles Affect lacZ Reporter Expression
Irrespective of The Promoter
A previous study of the hprl deletion showed that it affected the expression of
the PH05-lacZ or GALl-lacZ gene in yeast although hprl had no effect on endogenous
PH 05 or GAL1 expression (Chavez and Aguilera 1997). These and other results led to
the conclusion that HPR1 was required for efficient transcriptional elongation through the
lacZ gene (Chavez and Aguilera 1997). We used this observation that the lacZ gene
might contain specific sequences or structures that interfered with elongation to
determine whether defects in other factors known or presumed to play roles in
transcriptional elongation also failed to properly express lacZ. To conduct this analysis
we used three lacZ reporter constructs each of which contained a different promoter:
ADH2-lacZ, FKSl-lacZ, and GALl-lacZ (Liu et al 1998). These promoters were chosen
to represent genes that are constitutively expressed (FKS1), inducible (GAL1), and
subject to derepression by non-fermentative growth (ADH2). We subsequently analyzed
the effect of defects in transcription elongation and initiation factors with each of these
three reporters. As found for hprl, the rpb2-10, rpb2-4, spt5-4, and spt4 alleles conferred
large decreases in lacZ expression for all reporters tested (Table 3). These effects were
not likely to be due to effects on the respective promoters as spt5-4 does not reduce GAL1
or ADH2 expression (data not shown; also see Figure 3). rpb2-10 is known to reduce
GAL1 steady state mRNA but does so by only 1.4-fold (Wind-Rotolo and Reines, 2001),
and it had no effect on ADH2 derepression (Figure 3). In addition, these reductions in

22

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

lacZ expression by the spt5-4 and rpb2-l0 alleles were not the result o f increased rate of
lacZ mRNA degradation (data not shown).
Another rpb2-7 allele, which like rpb2-4 and rpb2-10 confers 6AU sensitivity
(Powell and Reines 1996), did not display a consistent major effect on the lacZ reporters
(Table 3). Other alleles of SPT5 (spt5-8 and spt5-242) had much less effect on lacZ
expression (Table 3). Moreover, defects in the elongation factors ELP1 (Otero et al
1999) or SPT16 (Oiphanides et al 1999) did not affect lacZ expression (data not shown).
We conclude that the rpb2-10, rpb2-4, spt5-4, and spt4 alleles are affecting an apparently
post-initiation step in the expression of the lacZ gene. Importantly, the rpb2-4- and rpb210-containing RNA pol II have been shown in vitro to display increased transcriptional
arrest whereas rpb2-7-RNA pol II did not (Powell and Reines 1996).
The effect o f a number o f factors important to transcriptional initiation was also
tested using this assay. Defects in none o f the CCR4-NOT complex components (except
not3-2) displayed consistent decreases in lacZ gene expression (Liu et al 1998; Chen et al
2001; data not shown). The not3-2 effect on lacZ expression was found, however, to
result from dramatic decreases in /acZ-reporter plasmid stability (data not shown).
Deleting the RNA pol II holoenzyme components SRB9, -10, -11, SIN4, and GAL11 also
displayed no consistent decreased effects on lacZ expression (data not shown). Deletion
of the SAGA components ADA2 and GCN5 also were found to only affect one or
another of the lacZ reporters but not all three, suggesting their effects were limited to
control of specific promoters (data not shown; Chiang et al 1996; Berger et al 1992).
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Table 3
Effects o f elongation defects on /acZ-reporter activities
Relative B-ealactosidase activitv

Strain

WT
hprl

FKSl-lacZ

ADH2-lacZ

GALl-lacZ

100

100

100

1.6

2.3

2.2
5.5

rpb2-4

20

12

rpb2-10

24

13

15

rpb2-7

N.D.

290

56

spt5-4

23

spt5-8

65

35

56

spt5-242

N.D.

59

51

spt4

2.9

4.9

1.5

4.1

0.50

Table 3: p-galactosidase activities were determined for each allele and its corresponding
isogenic wild-type parent containing the lacZ reporter as indicated. In order to ease
comparison between strains, all wild-type parent values were set to 100 for each reporter.
FKSl-lacZ was assayed on medium containing 4% glucose, ADH2-lacZ on 2%
ethanol/2% glycerol, and GALl-lacZ on 2% galactose/2% raffmose. All values represent
the average o f five separate transformants. Standard errors o f the mean (SEMs) were less
than 20%.
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The rob2-10. rob2‘4. sptS-4. And sot4 Alleles Reduce The Ability of RNA Pol II to
Form Full-length lacZ mRNA
To address whether transcriptional elongation through the lacZ gene was being
impaired by the above-described rpb2, spt5, and spt4 alleles, we used the quantitative SI
nuclease protection assay (Collart and Struhl 1993) to identify the abundance o f lacZ
transcripts that were full-length. To do this, we compared the abundance o f total lacZ
mRNA to the abundance of the full-length lacZ mRNA. Previously, it was shown using
Northern analysis that an hprl deletion blocked the synthesis o f lacZ mRNA (Chavez and
Aguilera 1997). In our assay system, hprl similarly displayed an inability to form fulllength lacZ mRNA regardless o f the promoter: in an hprl strain compared to its isogenic
parent, six-fold less full-length lacZ mRNA (corresponds to 3' end bands) was observed
as compared to total lacZ RNA (corresponds to 5' end bands) (Figure 1A; data not
shown).
As shown in Figures IB and 1C, the rpb2-10, rpb2-4, spt5-4, and spt4 alleles
which displayed consistent reductions in overall lacZ reporter expression concomitantly
displayed reduced levels of full-length lacZ mRNA formation as compared to the
quantity o f total lacZ mRNA that was present (Figure IB, two-to three-fold effects for
rpb2-4 and rpb2-10 and in Figure 1C, three- to seven-fold for spt5-4 and spt4). In
contrast, rpb2-7 (Figure IB), spt5-8, spt5-25 and spt5-194 (Figure 1C) had no significant
or less effect on formation of full-length lacZ mRNA. The same results obtained with
FKSl-lacZ (Figure 1) were obtained with ADH2-lacZ (data not shown), indicating that
these effects were independent o f the promoter. These data confirm a direct correlation
between the effect these elongation factors have on lacZ reporter expression and the
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Figure 1. SI nuclease protection analysis of the effect of HPR1, RPB2, SPT4 and SPT5
defects on full-length lacZ mRNA formation.
lacZ 5' and 3' end RNA levels were quantified using an SI nuclease protection assay with
probes directed against the 5' end of lacZ RNA and 2.9 kb downstream of the lacZ
initiation site, respectively (see Table 2). Total RNA was extracted and the ratios o f 3’ to
5’ RNA levels were quantified using a Phosphoimager. The values are normalized based
on the ratio for wild-type and the average ratio is given below each Figure except as
indicated.
(A) hprl reduces full-length lacZ mRNA formation. Strains AYW3-1B1 (WT, lane 1)
and AYW3-3D1 (hprl, lane 2) containing plasmids expressing FKSl-lacZ were grown
on 4% glucose-containing CAA-U medium. The values represent the average of five
determinations and the SEM for hprl was 20%.
(B) rpb2-4 and rpb2-10 alleles reduce full-length lacZ mRNA formation. Growth
conditions with FKSl-lacZ and calculations were conducted as described in (A). WT,
strain Z96 (lane 1); rpb2-4, strain Z100 (lane 2); rpb2-10, strain Z106 (lane 3) and rpb27, strain Z103 (lane 4). The values represent the average of five determinations for rpb2-4
with an SEM of 4%, four determinations for rpb2-10 with an SEM of 7%, and a single
determination for rpb2-7. Similar results were observed for rpb2-7 with the analysis of
ADH2-lacZ mRNA expression.
(C) spt5-4 and spt4 alleles reduce full-length lacZ mRNA formation. Growth conditions
with FKSl-lacZ and calculations were conducted as described in (A). WT, strain FY1642
(lane 1); spt5-4, strain FY1668-uH (lane 2); spt4, strain GHY180 (lane 3); spt5-194,
strain FY300 (lane 4); spt5-8, strain FY276-uT (lane 5); and spt5-25, strain L615 (lane
6). The spt5-4 value represents the average o f eight determinations with an SEM o f 8%.
The other values represent single determination, although similar results were obtained
for these defects with the analysis of ADH2-lacZ mRNA expression.
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Figure 1:
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formation o f full-length lacZ mRNA. Importantly, only the rpb2 alleles which displayed
reduced ability to transcribe through elongational blocks in vitro (Powell and Reines
1996) failed to form full-length lacZ mRNA in vivo.
It must be mentioned in regards to these SI analyses that our experiments indicate
in agreement with other studies (Luebke et al., 2003; Woolf et al., 1992) that
oligonucleotide probes, due to differences in length and sequence, can display different
degrees o f stable binding to the same mRNA and hence different apparent levels o f
mRNA. Because of these inherent differences in stability of binding between the
individual probes and a given mRNA, only the ratios of 5' to 3' mRNA levels can be
compared between a particular mutant and its isogenic parent. Also, several o f these
mutants can affect the overall abundance o f a particular mRNA that results in either an
increased or reduced level of total mRNA levels relative to that of wild-type (for
example, see spt5-4, Figure 1C). However, as we are interested in comparing the relative
ability o f different elongation defects to reduce the formation o f the full-length mRNA,
alterations in the level o f initiation of the transcript do not affect these comparisons.
The Effect on lacZ mRNA Formation Is Not Due to Increased mRNA 31End
Degradation.
The reduced level of formation o f full-length lacZ mRNA could be attributed
either to a block in elongation through the lacZ gene or to increased degradation o f the 3'
end o f the mRNA as compared to the degradation o f the 5' end. To address this latter
possibility we utilized the GALl-lacZ reporter to determine the rate of degradation o f the
5' and 3' ends o f the lacZ mRNA following the shutting off of GALl-lacZ transcription by
growth on glucose-containing medium. However, neither the spt5-4 nor the rpb2-10
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allele augmented the rate of degradation o f the 3' end o f the lacZ transcript relative to the
5' end (data not shown).
The Block to Transcriptional Elongation in lacZ Occurs at Multiple Sites
We subsequently examined where in the lacZ gene the block to elongation was
occurring using the SI nuclease protection assay with probes spaced across the lacZ gene.
In spt5-4, rpb2-4 and rpb2-l0 mutation backgrounds, lacZ mRNA synthesis appeared
unimpeded through the first 500 bp o f the lacZ gene (Figure 2). However, using probes
at 1.5,2.3, and 2.9 kb, decreased levels of lacZ 3'-end mRNA formation became
apparent. In moving from 1.5 to 2.9 kb, at each step an additional decrease in lacZ 3' end
mRNA formation was observed, suggesting the existence o f multiple sites for blockage
o f mRNA synthesis (Figure 2).
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Figure 2. spt5-4 and rpb2 alleles affect full-length lacZ RNA formation at multiple sites.
The 3' lacZ, probes for conducting the SI nuclease protection assays are listed in Table 2.
In all cases the 5' probe corresponded to sequences at the initiation codon o f lacZ.
Growth conditions, assays and analyses were conducted as described in Figure 1. The
rpb2 (panel A) and spt5-4 (panel B) strains contained FKSl-lacZ. The values represent
the data as presented, but two to three other repeats gave the same pattern of effects and
similar results were also observed when analyzing ADH2-lacZ.
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sot5 And rob2 Defects May Enhance Use of Cryptic Polv (A) Sites in lacZ
The above observations indicate that lacZ mRNA formation is particularly
sensitive to SPT5 and RPB2 defects. One model to explain this data is that
transcriptional pausing or arrest caused by the spt5-4, spt4, rpb2-10, and rpb 2-4 alleles
results in increased deposition of poly (A) site cleavage/adenylation factors at known
cryptic poly (A) sites located within the lacZ gene (Russnak et al 1995). Alternative
hypotheses for these effects at lacZ gene have been suggested for how hprl affects lacZ;
that is, the long length of lacZ or its high G-C content contributes to its impaired
transcription (Chavez et al 2001). spt5-4 and rpb2-10, however, unlike hprl had no
effect on transcription through the native YAT1 gene which is extremely G-C rich (Figure
3) and which is affected by hprl (Chavez et al 2001). Likewise spt5-4 and rpb2-10 did
not affect transcription through NOT1, a 6.5 kb transcript (Figure 3), suggesting that it is
not the length per se o f lacZ which is impeding expression. Finally, rpb2-4, rpb2-10, and
spt5-4 did not affect full-length ADH2 expression (Figure 3) although they all affected
ADH2-lacZ (Table 3; data not shown).
If the poly (A) usage model were correct, the incompletely formed lacZ RNA
would be polyadenylated. We would expect, therefore, that when polyadenylated
enriched RNA is analyzed that both spt5-4 and rpb2-10 should reduce the formation of
full-length lacZ mRNA to the same extent they reduced full-length lacZ RNA formation
when total RNA is analyzed. As shown in Figure 4, rpb2-10 and spt5-4 affected the
formation of full-length lacZ polyadenylated RNA to the same degree as they affected the
formation o f full-length lacZ RNA isolated from total RNA. These results support the
model that spt5-4 and rpb2-10 are enhancing utilization o f cryptic poly (A) sites in lacZ
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Figure 3. spt5 and rpb2 alleles do not affect elongation through the ADH2, NOT1 and
YATl gene.
Cells were grown on YEP medium containing 4% glucose (for NOT1), 2% galactose/2%
raffinose (for YATl) or 2% ethanol (for ADH2). 5' and 3' end RNA levels were
quantitated as described in Figure 1 using 5' and 3' probes specific to ADH2, NOT1 and
YATl respectively (Table 2). To quantitate YATl 5’ and 3’ RNA levels, yeast strains
were transformed with a GAL1-YAT1 plasmid (Chavez et al., 2001). The values represent
the data as presented but repetitions showed no significant differences.
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Figure 4:

Figure 4. rpb2-10 and spt5-4 alleles reduce full-length lacZ mRNA formation by
increasing partial-length lacZ mRNA formation.
Both total RNA (A: lanes 1 and 2; B: lanes 1 and 2) and poly (A) RNA (A: lanes 3 and 4;
B: lanes 3 and 4) were extracted and analyzed using an SI nuclease protection assay. SI
nuclease protection assays, growth conditions, and calculations were conducted as
described in Figure 1. The values represent the data as presented.
(A) WT, strain Z96 (lanes 1 and 3) and rpb2-10, strain Z106 (lanes 2 and 4).
(B) WT, strain FY1642 (lanes 1 and 3) and spt5-4, strain FY1668-uH (lanes 2 and 4)
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and are not simply causing RNA pol II to cease transcription, resulting in shortened
RNAs lacking poly (A) tails. Northern analysis, however, was unable to detect discrete
shortened RNAs, probably because o f multiple diffuse ends and more rapid turnover in
the cell of the shortened RNAs (data not shown).
sutS-4 And rob2-10 Enhance Utilization of Defective ADH2 Poly (A) Sites
If spt5-4 and rpb2-10 were causing increased pausing or arrest that results in
subsequent upstream poly (A) site utilization, then it would be expected that these
mutations should be able to enhance use o f known defective poly (A) sites found internal
to genes. To test this hypothesis, we utilized the previously described ADH2 defective
poly (A) sites that have been used in a poly (A) site usage assay (Hyman et al 1991). For
this assay, as shown in Figure 5A, the 3' end of the ADH2 gene containing its poly (A)
signaling sequences has been embedded within the RP51 intron. Usage of the ADH2
poly (A) cleavage site promotes the formation of a short mRNA that does not include
downstream RP51 sequences that are fused to lacZ. Read-through o f the poly (A) site, on
the other hand, promotes splicing of the intron and synthesis through lacZ. We
monitored these two alternative events by quantitating with an SI nuclease protection
assay the relative amount of mRNA that is expressed using either probe 1 that overlaps
the 5' RP51 junction of the exon and intron (thus measuring mRNA resulting from ADH2
poly (A) site usage) or probe 2 that is at 150 bp within the lacZ gene (thus measuring
RNA in which the poly (A) site has not been used and splicing has occurred). As shown
above in Figure 2, transcription through the first 500 bp of lacZ is unaffected by spt5-4 or
rpb2-10 alleles.
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Three plasmids containing this setup were used: pLIOl which has a wild-type
ADH2 y end sequence, pL401 which contains a T to G alteration upstream of the ADH2
poly (A) site that blocks ADH2 poly (A) site usage by 10-fold and pL402 which contains
two single nucleotide deletions upstream of the ADH2 poly (A) site that also blocks poly
(A) site usage (Figure 5A). As depicted in Figure 5B, in a wild-type strain, with pLIOl
the ADH2 poly (A) site is used and very little read-through mRNA is made (upper and
lower panel, lane 1). With both pL401 and pL402 (lanes 2 and 3, respectively) poly (A)
site usage is weakened at ADH2 and correspondingly read-through into the lacZ gene
occurs. These are the same results as previously obtained by Hyman et al 1991.
In an spt5-4 strain, however, the defective poly (A) sites in pL401 and pL402
display increased usage. The ratio o f ADH2 poly (A) site usage RNA to that of readthrough RNA increased about five-fold in both cases relative to the ratio observed in
wild-type (Figure 5B, upper panel, lanes 5 and 6 compared to lanes 2 and 3). In contrast,
the spt5-242 allele which does not affect lacZ expression correspondingly does not affect
poly (A) site usage in pL401 and pL402 (Figure 5B, upper panel, lanes 8 and 9). The
exact same results are obtained for the rpb2 alleles as observed for spt5. rpb2-I0, which
reduces lacZ expression, increased the ratio of poly (A) site usage RNA to that o f readthrough RNA by about three- and five-fold relative to the wild-type ratio in plasmids
pL401 and pL402, respectively (Figure 5B, lower panel, lanes 5 and 6, compared to lanes
2 and 3). rpb2-7 which does not affect lacZ also does not affect pL40l and pL402.
These data provide strong support for the model that the difficulties in transcribing
through the lacZ gene arise as a result of increased cryptic poly (A) site usage.
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One alternative explanation for these results with the ADH2 poly (A) usage assay
is that spt5-4 and rpb2-10 are decreasing the rate o f degradation o f the short mRNA that
terminates in the intron as compared to the read-through mRNA. This result is unlikely
in that as observed in lane 4, both upper and lower panels o f Figure 5B, spt5-4 and rpb210 do not correspondingly augment the levels o f the short mRNA relative to the long
mRNA. We did, however, quantitate the mRNA half-lives for the short and long mRNA
and found that spt5-4 had no effect on the half-life of either mRNA (data not shown).
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Figure 5. rpb2-10 and spt5-4 enhance utilization o f defective ADH2 poly (A) sites
embedded within the RP51 gene.
(A) The internal ADH2 poly (A) site assay as previously described (Hyman et al 1991) is
depicted. Plasmid pLIOl contains the RP51 locus fused to the lacZ gene in which the 3’
end o f ADH2 (containing the signals for poly (A) cleavage/adenylation) is inserted in the
RP51 intron. ADH2 poly (A) site usage results in a short transcript ending in the intron
that will be detected with probe 1 (5 ’-GCCTCCTTTAGTCCATATTAACATA
CCATTTTGTTATTGC-3’; see panel B, lane 1). Plasmids pL401 and pL402 contain the
same ADH2 sequence inserted in the intron of RP51 except each contains mutations in
theADH2 poly (A) recognition sequences resulting in substantial read-through and the
formation of full-length mRNA transcript that is detectable with probe 2 (5’GCGCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGAT
CGGTGCGGGCCAGAA-3’; see panel B, lanes 2 and 3).
(B) SI nuclease protection analysis of the relative levels o f read-through and short
transcripts. Strains were pregrown in 4% glucose-containing CAA-IT medium at 30°C for
20 hr, and then shifted to CAA-IT medium with 2% galactose/2% raffinose at 30°C for 4
hr. RNA was subjected to SI nuclease protection assays as described in Figure 1 using
probe 1 and 2 (panel A).
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rob2-16 Reduces Full-len2th mRNA Formation From Yeast Genes That Contain
Internal Polv (A) Sites
Since rpb2-10 has been shown to increase pausing/arrest in vitro the most likely
interpretation o f the above results is that increases in pausing downstream o f the ADH2
poly (A) site caused by the rpb2-10 allele promotes greater deposition of poly (A) site
cleavage/adenylation factors at the ADH2 poly (A) sites. These results also imply that
rpb2-10 pausing will become manifest in reduced full-length gene expression o f native
yeast genes if partially functional poly (A) sites are present internal to a gene. In yeast,
three genes, RNA14, AEP2, and CBP1, have been shown to contain internal inefficiently
utilized poly (A) sites (Sparks and Dieckmann 1998; Sparks et al 1997). RNA14 contains
two such sites whereas AEP2 and CBPI each contain one. We, therefore, assayed the
effect of rpb2-10 and rpb2-7 on the expression through RNA14, AEP2, and CBPI (Figure
6). Using 5' and 3' probes to the RNA14 mRNA, rpb2-10 reduced the level o f the 3' RNA
relative to the amount of 5' RNA (Figure 6, upper panel, lane 5 compared to lane 4).
Over seven such experiments the average drop in the 3’:5’ ratio in an rpb2-10 mutant was
0.62±0.045 (SEM). The rpb2-7 allele again displayed much less of an effect (Figure 6,
upper panel, lane 6) for an average decline in the 3':5’ ratio for five determinations of
0.91± 0.082.
We reexamined these results using Northern analysis to verify whether one or
both o f the RNA14 internal poly (A) sites was being preferentially affected. As shown in
Figure 7, lanes 3 and 5, rpb2-10 resulted in diminished full-length mRNA formation and
augmented levels of the shortest (1.1 kb) mRNA. This result agrees with the SI analysis
displayed in Figure 6, top panel. It suggests further that the two internal poly (A) sites in
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RNA14 might behave differently or that there are specific sequences across the RNA14
gene that display different responsiveness to rpb2-10. Importantly, rpb2-10 also reduced
CBPI full-length formation (Figure 6, lower panel, lane 4) and that o f AEP2 (Figure 6,
middle panel, lane 4). As mentioned above, rpb2-10 did not affect expression through
several other genes analyzed, ADH2, NOT1, and YAT1, indicating that it specifically
affects expression through genes containing internal poly (A) sites. However, hprl had
no affect on RNA14 full-length expression (Figure 6, upper panel, lane 8) or that o f AEP2
(middle panel), confirming that hprl operates by a different mechanism than rpb2-10 in
affecting elongation. It should be noticed that rpb2-7 did display some enhanced internal
poly (A) site utilization at RNA14 (Figure 7, lane 3) and at AEP2 (Figure 6, middle panel,
lane 5). While these effects are consistently less than that observed with rpb2-10, they do
indicate that the rpb2-7 allele, which confers a 6AU phenotype in vivo (Powell and
Reines, 1996), consistent with an elongational defect, can affect elongation under certain
in vivo condition.
spt5-4 also resulted in decreased full-length formation for RNA14 (Figure 6, upper
panel, lane 2) with an average fold decrease in the 3’:5’ ratio o f 0.67± 0.046 for six
experiments. In contrast, spt5-242 had little apparent effect on full-length RNA 14
expression (Figure 6, upper panel, lane 3) with an average drop in the 3’:5’ ratio of 0.91±
0.12 for four experiments. These results were also confirmed by Northern analysis
(Figure 7). spt5-4, however, displayed no consistent effect on CBPI or AEP2 expression
(Figure 6A, lower and middle panel, respectively), suggesting that either there is
sequence specificity to its pausing, its effects are weaker, or that the multiple poly (A)
sites within RNA14 allow greater amplification o f its putative pausing.

40
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure 6. rpb2-10 and spt5-4 reduce full-length expression o f yeast genes containing
internal poly (A) sites.
Cells were grown on minimal medium with 4% glucose overnight and shifted to 2%
glycerol-containing minimal medium for 6 hours. SI nuclease protection assays were
conducted as described in Figure 1 using probes specific to the 5’ and 3’ ends o f RNA 14,
CBPI, and AEP2 (Table 2). The values represent the average of three to seven repetitions
except for hprl and for the rpb2-7 effect on CBPI which were single experiments. SEMs
not indicated in the text were less than 10% except for rpb2-10 on CBPI which was 20%.
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Figure 7

RNA14

*• 2.2 kb

Figure 7. Northern analysis indicates that spt5-4 and rpb2-10 cause reduced full-length
RNA 14 mRNA formation and increased internal poly (A) site utilization.
Cells were grown as described in Figure 6. Both total RNA (lanes 1 to 3) and poly (A)
RNA (lanes 4 to 7) were extracted and subjected to Northern analysis using the 5 ’ probe
from RNA14. Values represent the data as presented. Repeat experiments gave similar
data.
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Deletion of TFIIS Also Reduces Full-length Expression of RNA14
The above results indicate that defects in transcriptional elongation in vivo can be
visualized by monitoring the use o f internal poly (A) sites. It had already been previously
shown that a dstl deletion blocks GALl-lacZ expression (Kulish and Struhl 2001). We
subsequently examined the effect of dstl using the defective ADH2 poly (A) signal
inserted into the RP51 gene. As shown in Figure 8A, lane 4 compared to lane 2, dstl, like
rpb2-10 and spt5-4 (Figure 5B), caused the formation o f increased truncated RPSl RNA
(for dstl lane 4, about 2.0-fold more shortened transcript relative to read-through
transcript as compared to that found in wild-type, lane 2), consistent with dstl
augmenting internal ADH2 poly (A) site utilization. To further test this hypothesis we
subsequently examined the effect of a TFIIS deletion on RNA 14 expression. As shown in
Figure 8B, a dstl deletion reduced full-length RNA expression by 1.6-fold. This result
was confirmed by Northern analysis in which the shortest transcript was increased in
abundance relative to the full-length transcript by two-fold (Figure 8C). Combining a
dstl deletion with an rpb2-10 allele did not result, however, in any significantly worse
effects than observed with just the rpb2-10 allele alone (Figure 8C). These observations
identify the first native gene in vivo whose elongation is impaired by deletion o f TFIIS
and confirm the use of the poly (A) amplification elongation assay.
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Figure 8. dstl has similar effects on full-length RNA formation as rpb2-10.
(A) WT, strain Z96 (lanes 1 and 2) and dstl, strain DY106-U (lanes 3 and 4) were
analyzed for their effects on ADH2 poly (A) site usage as described in Figure 5B.
Plasmids pLIOl and pL401 are as in Figure 5.
(B) RNA14 full-length RNA expression was analyzed as described in Figure 6. Total
RNA was extracted from strains Z96 (WT), Z103 (rpb2-7), Z106 {rpb2-10), DY106-U
(dstl) and DY108 (dstl rpb2-10). Values represent the data as presented. Repeat
experiments gave similar data.
(C) Northern analysis of RNA 14 mRNA levels in strain backgrounds described above
was conducted as described in Figure 7. Values represent the data as presented. Repeat
experiments gave similar data.
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rob2-10 And sot5-4 Affect Polv (A) Site Usage at The 3’ End of Genes
Differential poly (A) site choice at the 3’ ends o f genes can be regulated in
response to a variety of biological influences (Edwalds-Gilbert et al., 1997). The above
effects of elongation defects on internal upstream poly (A) site utilization suggest that
elongation may also play a role in regulating poly (A) site choice. To test this prediction,
we analyzed poly (A) site utilization for the GAL1 gene which contains two poly (A) sites
about 50 and 160 bp downstream o f its translation stop codon (Graber et al., 2002;
Miyajima et al., 1984, see Figure 9, top panel). Newly synthesized GAL1 polyadenylated
mRNA were created by inducing GAL1 expression for 15 minutes in galactosecontaining medium followed by repression o f GAL1 mRNA synthesis with the addition
o f glucose. The 3’ ends of GAL1 mRNA were detected using an RNase H assay (Tucker
et al., 2001) and a DNA probe that was complementary to sequences present in both
species (Figure 9, top panel). Two polyadenylated species migrating at about 380 and 275
nt were identified (Figure 9, bottom panel) that corresponded to poly (A) sites at about
160 bp and 50 bp, respectively, downstream o f the GAL1 stop codon. Each mRNA
species contained 80 nt of poly (A) as determined by a deadenyiation assay (data not
shown; Tucker et al. 2001). As shown in Figure 9, lanes 1 and 4, the downstream site is
preferred by about two-fold over the upstream site in the wild-type strain. In a rpb2-10
background, the use of the GAL1 upstream poly (A) site was increased by about 2-fold
(Figure 9, lane 3, rpb2-10, compared to lane 1, wild-type), whereas the rpb2-7 allele had
no effect on GAL1 poly (A) site utilization (Figure 9, lane 2). Similarly, in an spt5-4 or
spt4 strain background, the use of the upstream site is increased by 1.6-fold and 2.0-fold,
respectively (Figure 9, lanes 5 and 6). The spt5-242 allele which does not affect internal
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Figure 9. rpb2-10, spt5-4 and spt4 affect 3’ end poly (A) site choice at GALL
Top panel - Diagram of GAL1 gene RNA. The two poly (A) sites located 50 bp and 160
bp downstream of the stop codon are indicated as are the RNase H probe and the
Northern probe. Bottom panel - Northern analysis of GAL1 mRNA.
Yeast were grown on galactose-containing medium for 15 minutes followed by glucose
addition upon which total RNA was extracted. Newly synthesized GAL1 polyadenylated
mRNA species were detected using an RNase H assay (Tucker et al., 2001). GAL1
specific transcripts were identified by Northern analysis. The larger RNA species
(migrating at about 390 nt) corresponds to a poly (A) cleavage site about 160 bp
downstream of the GAL1 gene translation stop codon and the smaller RNA (migrating at
about 275 nt) to a cleavage site about 50 bp downstream of the stop codon. Each mRNA
species carries a poly (A) tail measured at about 80 nt by a deadenylation assay (data not
shown). The values represent the average ratio of the 275 nt species to that o f the 390 nt
species for two to five determinations with SEMs less than 20%.
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poly (A) site utilization (see above) had no effect on augmenting the GAL1 upstream poly
(A) site usage (data not shown). rpb2-10, spt5-4, and spt4 also did not enhance the
stability of the short GAL1 mRNA relative the that of the long GAL1 mRNA (data not
shown). These results confirm our prediction that elongation defects enhance utilization
of upstream poly (A) sites and indicate that regulating the elongation process will be
critical to 3’ end poly (A) site choice.

Discussion
In this report we have identified native yeast genes whose full-length mRNA
formation is significantly reduced by defects in the elongation factors RPB2, SPT5 and
TFIIS. The experiments represent the first demonstration in vivo o f genes whose
transcriptional elongation is regulated by these factors as previous studies, including
microarray analyses, were unsuccessful in clearly identifying such genes (Hemming et
al., 2000; Shaw and Reines, 2000; Wind-Rotolo and Reines, 2001). In addition, we have
shown that expression through other chimeric yeast gene constructs and that o f the E. coli
lacZ gene are also affected by RPB2, SPT5 and TFHS defects. The common feature of
these genes and constructs is their containing internal poly (A) sites. These observations
should aid the study of elongation in vivo and allow the development o f genetic assays
for the identification of novel elongation factors and new relationships among known
factors.
It has been shown previously in vitro and in vivo that transcriptional pausing
downstream to a poly (A) site promotes polyadenylation/cleavage o f the RNA both in
yeast and mammalian cells (Birse et al. 1997; Aranda and Proudfoot 1999; Yonaha and

48
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Proudfoot 1999). These observations are consistent with several observations for the
requirement o f RNA polymerase II in 3' processing (Hirose and Manley 1998;
McCracken et al 1997(Proudfoot et al., 2002). We have established in this report that
defects in the SPT5, SPT4, RPB2 and TFIIS, all factors involved in transcriptional
elongation, affect the mRNA formation in vivo of genes containing internal poly (A)
sites. We postulate, therefore, that transcriptional pausing caused by defects in elongation
factors enhances the internal poly (A) site usage and consequently increases truncated
mRNA formation relative to full-length mRNA.
Several pieces of evidence support our hypothesis. First, mutations in SPT5, SPT4
and RPB2 (such as spt5-4, spt4, rbp2-4 and rpb2-10 alleles) reduced full-length lacZ
RNA formation, a gene known to contain cryptic poly (A) sites (Russnak et al., 1995).
Other SPT5 or RPB2 mutations had no effect on full-length lacZ RNA formation,
indicating that this effect was allele specific. Second, the truncated lacZ RNA were
polyadenylated. Third, these SPT5 and RPB2 defects did not affect the full-length mRNA
formation for genes, such as YAT1 or NOT1, containing high G-C content or excessive
length which lacked internal poly (A) sites, indicating that their effects on elongation
occurred by a mechanism different from or in addition to that ascribed to HPR1 (Chavez
et al 2001). Fourth, we showed that spt5-4, rpb2-10 and dstl alleles can enhance the
usage of defective ADH2 poly (A) sites embedded within the RP51 gene. Other SPT5 or
RPB2 alleles which did not affect lacZ expression also had no effect on ADH2 defective
poly (A) site usage. Importantly, the rpb2-10 allele which is known to cause increased
pausing in vitro and to block in vitro transcriptional elongation resulted in enhanced
internal poly (A) sites usage whereas the rpb2-7 allele which does not block in vitro

49
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

elongation did not display the same effects. Fifth, we showed that full-length RNA
formation of several yeast genes with known internal poly (A) sites displayed decreased
full-length mRNA expression with rpb2-10 and to a lesser extent with spt5-4 and dstl.
Finally, the rpb2-10, spt5-4 and spt4 defects affected 3’ end poly (A) site choice in which
the usage o f the upstream poly (A) site became preferred in strains carrying these defects.
That the usage of the upstream poly (A) site is always enhanced relative to that of
the downstream site with these elongation mutations suggests that RNA pol II pausing is
occurring throughout the gene and that deposition of poly (A) site cleavage factors
becomes favored at the first available poly (A) signal. Our results also imply that at
normal genes where rpb2-10 is not having an apparent effect on 3' end formation, such as
ADH2, NOT1, YAT1, or the first 1.0 kb o f lacZ, rpb2-10 induced RNA pol II pausing is
probably still occurring but is not significant enough in vivo to cause reduced levels o f 3’
RNA formation relative to that o f 5’ RNA levels. Only when a cryptic or defective poly
(A) site is present can the pausing be "amplified" and visualized as reduced normal 3' end
formation due to increased poly (A) site usage. This interpretation is consistent with the
observation that rpb2-10 did not appear to affect transcription in vivo even when a known
in vitro arrest site is introduced into a gene (Wind-Rotolo and Reines, 2000). Relatedly,
dstl did not affect RNA pol II occupancy at the lacZ gene (Kulish and Struhl, 2001),
implying that enhanced pausing caused by dstl or rpb2-10 may not have noticeable
effects on measurable RNA pol II association with the gene. The known effects o f rpb210, dstl, spt5-4 or spt4 on many genes’ expression either positively or negatively
(Swanson and Winston, 1992; Wind-Rotolo and Reines, 2001) must therefore be
interpreted carefully as to whether they are due to transcriptional initiation or elongation
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defects. That is, although we did not observe with these defects reductions in full-length
mRNA formation for long genes, such as NOT1, or genes with a very high G-C content,
such as YAT1, this does not imply that spt5, rpb2, or dstl strains were not impaired in
transcribing through these genes. For example, YAT1 total mRNA expression was
decreased in an spt5-4 or rpb2-10 background, but we are unable to ascertain whether
this effect is at the level o f transcriptional initiation or not.
Interestingly, it has been shown that non-fermentative growth conditions promote
increased poly (A) site cleavage at the RNA14 1.1 kb site and enhanced internal poly (A)
site cleavage at CBPI and AEP2 (Sparks and Dieckmann 1998). These effects o f nonfermentative growth on RNA14, CBPI, and AEP2 expression are similar to that observed
for rpb2-10 and suggest that they occur by a similar mechanism, that is, by causing
increased RNA pol II pausing. Several stress conditions have also been observed to
enhance SUA7 upstream poly (A) site utilization (Hoopes et al., 2000). Non-fermentative
growth and other stress conditions may be impairing elongation and thereby altering poly
(A) site utilization. However, the effects of the several elongation defects on internal poly
(A) site usage that we observed would occur in addition to the non-fermentative growth
effect since all of our experiments were conducted under glycerol growth conditions.
While rpb2-10 can result in decreased full-length RNA formation for several
yeast genes containing internal poly (A) sites such as RNA14, CBPI and AEP2 (Sparks
and Dieckmann 1998; Sparks et al 1997) and differential 3’ end poly (A) usage at GAL1,
spt5-4 only clearly affected full-length RNA14 RNA formation and 3’ end choice of
GALl. This difference in behavior may be due to sequence differences between RNA14,
CBPI and AEP2. While CBPI and AEP2 contain one internal poly (A) site, RNA 14

51
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

contains two internal poly(A) sites, which may allow a greater amplification o f the effect
caused by pausing/arrest. RNA14 and the 3’ end o f GAL1 may also contain specific
sequences that can result in more pausing. Alternatively spt5-4 allele may have a weaker
effect on elongation as compared to rpb2-10.
It could be argued that the spt5, spt4, rpb2 and dstl alleles are affecting fulllength RNA formation, not by blocking RNA elongation, but by directly enhancing the
polyadenylation/cleavage process at upstream poly (A) sites. While we cannot formally
exclude this possibility, several factors suggest otherwise. First, these alleles have
displayed a number o f effects on elongation and are known to be involved in elongation.
Second, in vitro evidence has shown that rpb2-10 causes RNA pol II to pause while rpb27 had no effect (Powell and Reines 1996). Similarly, rpb2-10 can strongly decrease fulllength lacZ RNA formation and enhance defective ADH2 poly (A) site usage whereas
rpb2-7 had no effect in our experiments. Although rpb2-7 did reduce RNA14, CBPI and
AEP2 full-length RNA formation to a limited extent, rpb2-10 again displayed much
stronger effects. In addition, while SPT5 has been indicated to play a role in transcription
initiation, elongation, and mRNA capping (Swanson and Winston 1992, Swanson et al
1991, Wada et al 1998, Hartzog et al 1998; Yamaguchi et al 1999, Pei and Shuman
2002), it has not been identified as affecting polyadenylation/cleavage directly. Finally,
known defects in poly (A) cleavage/adenylation factors reduce poly (A) site utilization
and have not been shown to enhance upstream poly (A) site use as presented herein.
However, in mammalian systems, alternations in the activity or abundance o f the 64 kDa
subunit of CstF polyadenylation factor can in some circumstances influence poly (A) site
choice (Edwalds-Gilbert et al., 1997). It remains possible therefore that the rpb2-10, spt5-
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4, and dstl defects could exert indirect effects on the activities of poly (A)
cleavage/adenylation factors.
Many genes with alternative poly (A) sites have been identified and characterized
in mammalian cells, yeast and several types o f viruses. Differential poly (A) site choice
of some genes is regulated by development stages or in different tissues in mammalian
cells (see review by Edwalds-Gilbert et al. 1997). Using EST data, more than 5000
human and 1000 mouse genes have been identified with two or more poly (A) sites
(Beaudoing and Gautheret 2001). Therefore, regulation o f poly (A) site choice is an
important method for regulating mRNA levels in different cellular environments. The
results presented herein indicate that the elongation process, through effects on
transcriptional pausing or arrest, may also regulate mRNA levels by affecting poly (A)
site choice. Since the same mRNA with different poly (A) site ends can display vastly
different deadenylation rates and mRNA stabilities, altering poly (A) site choice could
greatly influence protein translation and abundance in the cell. In addition, more than
1000 yeast genes could contain internal poly (A) sites (Graber et al 2002). It is obvious,
therefore, that the proper regulation of pausing/arrest in vivo will be extremely important
to maintaining both formation and fidelity o f full-length mRNA.
Not only do our results confirm an in vivo connection between transcription
elongation and polyadenylation/cleavage, but also they provide a method to examine
transcriptional elongation in vivo. The amplified utilization of internal poly (A) sites that
occurs as a result o f defects in elongation factors can be used to develop appropriate
genetic assays for identifying novel elongation factors, elucidating their mechanisms in
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transcriptional elongation, and for analyzing the types o f DNA sites that affect
transcriptional elongation in vivo.
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CHAPTER n

SPT5 AFFECTS RATE OF mRNA DEGRADATION THROUGH PHYSICAL
INTERACTION WITH AND INHIBITION OF CCR4 DEADENYLASE ACTIVITY

Introduction
The levels of eucaryotic mRNA can be regulated at many steps, from its initial
synthesis to its eventual degradation in the cytoplasm. Regulation of the rate o f mRNA
decay is an important control point in determining the abundance of cellular mRNA. The
mature mRNA bears a 5’ cap structure and 3’ poly (A) tail that protect the mRNA from
degradation. A principal mRNA-decay pathway in eucaryotic cells is initiated by
shortening o f the poly (A) tail at the 3’ end (deadenylation) which is then followed by
removal of the 5’ cap structure (decapping) and subsequent 5’ to 3’ exonuclease digestion
(Decker and Parker, 1993; Hsu and Stevens, 1993; Muhlradetal., 1994; M uhlradetal.,
1995; Muhlrad and Parker, 1992).
Deadenylation is a key rate-limiting step in the decay of mRNA in that it is the
initial step for mRNA degradation and the mRNA deadenylation rate can directly affect
the overall mRNA turnover rate (Cao and Parker, 2001; Couttet et al., 1997; Decker and
Parker, 1993; Muhlrad et al., 1994; Muhlrad et al., 1995). It has also been shown that the
poly (A) tail is capable of stimulating the translation of mRNA (Sachs et al., 1997; Wells
et al., 1998) and inhibiting decapping in an elF4E-independent manner (Wilusz et al.,
2001). Therefore, understanding the mechanism by which mRNA deadenylation occurs
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and its regulation is very important for our understanding o f the regulation o f mRNA and
protein levels.
In yeast, the evolutionarily conserved CCR4 protein, as part o f the CCR4-NOT
complex, has been identified as the major cytoplasmic deadenylase (Chen et al., 2002;
Tucker et al., 2002; Tucker et al., 2001). While PAN2/PAN3, as poly (A) nuclease
processes the poly (A) tails of mRNA in the nucleus (Brown and Sachs, 1998; Brown et
al., 1996), CCR4 performs its deadenylase function in the cytoplasm (Tucker et al.,
2001). Biochemical and bioinformatic studies have shown that CCR4 protein contains
three major functional domains: an N-terminal activation domain that may interact with
the transcriptional machinery, a central leucine-rich repeat (LRR) domain that binds
CAF1 and several other putative components o f the 1.9 MDaCCR4-NOT complex, and a
C-terminal exonuclease HI like domain that comprises the apparent CCR4 deadenylase
function (Chen et al., 2002; Draper et al., 1994; Draper et al., 1995; Liu et al., 2001; Liu
et al., 1997; Tucker et al., 2002).
The CCR4-NOT complex acts at several junctures in the formation o f mRNA.
Not only can the CCR4-NOT proteins, as the cytoplasmic deadenylase complex, act to
control the degradation o f mRNA (Chen et al., 2002; Daugeron et al., 2001; Tucker et al.,
2002; Tucker et al., 2001), these factors also function in repressing the initiation of
transcription through TFIID contacts (Badarinarayana et al., 2000; Deluen et al., 2002;
Lemaire and Collart, 2000), in transcriptional elongation (Denis et al., 2001), and in the
activation of transcription (Denis, 1984; Liu et al., 1998; Sakai et al., 1992). Consistent
with their multiple functions, the CCR4-NOT proteins have been localized to both
nuclear and cytoplasmic compartments (Tucker et al., 2002; Tucker et al., 2001).
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Therefore, an important issue is how the regulation of each of these functions occurs at
the appropriate location and time.
In this study, we identified a physical and functional connection between the
CCR4-NOT complex and SPT5. SPT5 forms a complex with the SPT4 protein (Hartzog
et al., 1998), called DSIF in mammalian cells (Wada et al., 1998a). SPT5/SPT4, like
CCR4-NOT complex, is conserved throughout eukaryotes and has been found to be
involved in multiple steps o f mRNA processing. SPT5/SPT4 works in conjunction with
both the positive transcription elongation factor b (P-TEFb) and RNA pol II to control
transcriptional elongation (Hartzog et al., 1998; Kim et al., 1999; Yamaguchi et al.,
1999b). SPT5/SPT4 has also been found to interact with the mRNA capping enzyme and
cap methyltransferase. Moreover, SPT5/SPT4 defects lead to accumulation of unspliced
pre-mRNA (Lindstrom et al., 2003; Wen and Shatkin, 1999). These indicate a role for
SPT5/SPT4 in pre-mRNA processing. Relatedly, in Drosophila, SPT5 has been found to
associate with RNA processing exosome (Andrulis et al., 2002).
Yueh-Chin Chiang has reported that immunoprecipitation o f SPT5 coimmunoprecipites multiple CCR4-NOT components and that in vitro, purified CAF1, and
the CCR4-C-terminus can each bind purified SPT5. We subsequently determined that
several spt5 alleles and an spt4 deletion can reduce the degradation rate of ADH2 and
GAL1 mRNA, and that the same alleles can decrease GAL1 mRNA deadenylation rate.
While the majority o f SPT5 localizes to the nucleus, some SPT5 is present in the
cytoplasm. Finally, we showed that SPT5 can inhibit CCR4 deadenylase activity in vitro.
These observations indicate that SPT5 can affect mRNA degradation through its
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interaction with and inhibition of CCR4 deadenylase activity. These data also imply that
SPT5 may be important in regulating CCR4 deadenylase activity in the nucleus.

Materials and Methods
Yeast Strains And Growth Conditions
Yeast strains are listed in Table 1. Strains containing spt5 or spt4 alleles are all
isogenic to FY1642 (wild-type) except as indicated (Hartzog et al., 1998). Yeast were
grown on YEP medium (1% yeast extract/2% bactopeptone), minimal medium or CAAU medium (Liu et al 1998) supplemented with an appropriate carbon source as indicated
in the Figures. The plasmid pCAFl is YEpl3-CAFl-U whose LEU2 gene has been
converted to URA3.
Immunofluorescence Assay
The localization of Flag-Tagged SPT5 in the cells was determined by indirect
fluorescent immunostaining. FY1639 and FY1642 were grown to midlog stage and
analyzed by standard methods using anti-Flag antibody at a dilution o f 1:200 and FITCconjugated goat anti-mouse IgG at 1:400 dilution.
RNA Analysis
Quantitative SI nuclease protection assays were conducted as described (Collart
and Struhl, 1993). Control experiments in each case indicated that at the concentration of
SI nuclease used, no radioactively labeled oligonucleotide remained if no RNA was
present and that the SI nuclease assay was linear over the concentration o f RNAs used.
Total RNA were purified as described previously (Cook and Denis, 1993; Denis et al.,
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1983). Oligonucleotides were radiolabelled at their 5’ end with T4 polynucleotide kinase
as described (Chen et al., 2002).
The polyadenylated species of GAL1 and MFA2pG mRNA were analyzed by
using transcriptional pulse-chase and RNase H assay as described previously (Decker and
Parker, 1993; Muhlrad and Parker, 1992). A 18-nt DNA probe (5’GCCATTTGGGCCCCCTGG-3’) complementary to the sequences 133 bp upstream of
the GAL1 translation stop codon was hybridized to total yeast RNA prior to RNase H
cleavage (Muhlrad and Parker, 1992). The resultant GAL1 3’ polyadenylated species
were detected by Northern analysis using a probe that was complementary to the 3’ end
o f GAL1 (5’GCCCAATGCTGGTTTAGAGACGATGATAGCATTTTCTAGCTCAGCATCAGTGA
TCTTAGGG-3’)- MFA2pG transcript was detected directly by Northern analysis using a
probe as described previously (Decker and Parker, 1993).

Results
sptS-4. sptS-194 And spt4 Deletion Can Reduce the Rate of mRNA Degradation.
As SPT5 specifically interacts with the C-terminal region o f CCR4 that comprises
the CCR4 deadenylase function (Chen et al., 2002) and with CAF1, we hypothesized that
SPT5 might be regulating the rate o f mRNA degradation through its contacts to CCR4NOT components. We subsequently examined the effect of several spt5 alleles and an
spt4 deletion on the rate o f ADH2 mRNA decay. CCR4 has been shown previously to
affect ADH2 mRNA degradation rate (Chen et al., 2002).
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We observed that ADH2 mRNA was stabilized approximately 2- to 3-fold in spt5194, spt5-4, and spt4 deletion strain backgrounds as compared to wild type (Figure 10).
In the same strain background, a ccr4 deletion also resulted in a 2.5-fold stabilization of
ADH2 mRNA. Combining ccr4 with spt5-4, spt5-194, or spt4 did not further slow the
rate o f ADH2 mRNA degradation. In contrast, in spt5-25 and spt5-242 strain
backgrounds, the rate of ADH2 mRNA decay was not affected (Figure 10, left panel),
ccr4, however, in combination with spt5-242 or spt5-25 still decreased the rate o f ADH2
mRNA degradation by 2-fold (data not shown). We also observed that spt5-4, like ccr4,
slowed the rate of GAL1 mRNA degradation by two-fold whereas spt5-242 did not (data
not shown). These results indicate that certain alleles o f spt5 or deletion of spt4 result in a
slowing mRNA decay. The observation that effect of ccr4 and these spt5/spt4 alleles on
mRNA degradation is not additive suggests that CCR4 and SPT5/SPT4 are functioning in
the same pathway in regards to mRNA degradation.
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Figure 10. spt5 and spt4 alleles affect ADH2 mRNA degradation rate.
Wild-type and mutant strains (see Table 1) were pregrown on YEP medium containing
2% ethanol prior to shifting to medium containing 4% glucose at zero time and the taking
o f RNA samples at the times indicated. The ADH2 mRNA levels were determined by an
SI nuclease protection assay using probe corresponding to sequences 1126 bp
downstream o f HheADH2 translation start codon (5’GGCATACTTGATAATGAAAACTATAAATCGTAAAGACATAAG-3’). The ACT1
RNA was used to standardize loadings for RNA samples at the different time points
indicated. ACT1 probe is complementary to the sequences 1039 bp downstream of the
ACT1 translation start codon (5’-CCACTTTCGTCGTATTCTTGTTTTGAGATCCAC
ATTTGTTGGAAGGTAGTCAAAGAAGC-3 ’).
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SPTS And SPT4 M utations Affect mRNA Deadenvlation But Not Decapping
The effect of SPT5/SPT4 on mRNA degradation could be occurring by altering
the rate of deadenylation, decapping or 5’ to 3’ degradation o f RNA transcript (Beelman
and Parker, 1995). A simple test to determine whether defects in mRNA decay occurs at
the decapping or later step is to analyze the production of degradation products o f the
MFA2pG RNA relative to the total level of MFA2pG present (Tharun and Parker, 1999).
MFA2pG gene contains a poly (G) tract insertion in the 3 ’ UTR, which inhibit
exonuclease activity (Decker and Parker, 1993). Therefore, a poly (G) to 3’ end RNA
fragment will accumulate when the decapped mRNA is degraded from the 5’ to
3’direction. However, in the absence o f any decapping and 5’ to 3’ mRNA digestion, the
formation o f the poly (G) to 3’ end RNA fragment will be blocked. As shown in Figure
5A, like ccr4 (Figure 11A, lane 3), spt5-4 has no obvious effect on the formation o f poly
(G) to 3’ end mRNA fragment (Figure 11A, lane 2 compared to lane 1). Since these
results indicate that the spt5/spt4 alleles are not affecting decapping or subsequent 5’
RNA degradation, we tested whether these alleles affected the rate o f mRNA
deadenylation, the same step that CCR4 and CAF1 control. Changes in the mRNA
deadenylation rate was followed using a transcriptional pulse chase analysis (Decker and
Parker, 1993) with the GAL1 mRNA. Expression of GAL1 was rapidly induced for 15
minutes by adding galactose to raffinose growth culture and then repressed by adding
glucose. The deadenylation o f this pool of newly synthesized GAL1 mRNA was
monitored at different time points by Northern analysis.
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Figure 11. spt5 and spt4 alleles affect mRNA deadenylation but not decapping
(A). Wild-type (FY1642), spt5-4 (FY1668-uH), and ccr4 (FY1642-la) strains containing
plasmid RP??? were grown in CAA-LT medium with 4% glucose to midlog stage. Total
RNA was extracted after shifting to 2% galactose for 4 hours. MFA2pG transcripts were
detected by using transcriptional pulse-chase assay (Decker and Parker, 1993). The upper
band represents the full-length MFA2pG transcript and the lower band corresponds to the
poly (G) to 3’ end RNA fragment.
(B). Wild-type (FY1642), spt5-4 (FYI668-11H), spt5-242 (FY1635), and spt4 (GHY180)
strains were shifted from raffinose-containing YEP medium to galactose-containing YEP
medium for 15 minutes to induce GAL1 gene expression. After transcriptional repression
by the addition o f glucose, total RNA were extracted at different time point as indicated
and RNase H digestion was conducted and Northern analysis was used to detect the
GAL1 specific mRNA.
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Table 4 deadenylation rate of GAL1
mRNA in wild-type, spt5, and spt4 strains
deadenylation rate
(nucleotide/minute)
2.9 ±0.28
3.3±0.42
2.110.12
2.110.14

strain
wild-type
spt5-242
spt5-4
spt4 deletion

As shown in Figure 1 IB, we observed that, in a wild-type strain, the poly (A) tail
is degraded to an oligo (A) tail length o f approximately 8-13 A ’s by around 10-15
minutes, followed by slow deadenylation of the oligo (A) tail. It has been shown
previously that decapping and 5’ to 3’ degradation o f the transcript occurs once the oligo
(A) tail form appears (Couttet et al., 1997; Decker and Parker, 1993; Muhlrad et al.,
1994). The rate of GAL1 mRNA deadenylation was found to about 2.9 A’s per minute.
Similarly in the spt5-242 strain which had no effect on ADH2 or GAL1 mRNA decay
rate, the poly (A) tail was shortened at a rate o f approximately 3.3 nucleotides per
minutes (Table 4), with a portion of GAL1 mRNA with oligo (A) tail observed also in 10
to 15 minutes (Figure 1IB, left panel). In contrast, in spt5-4 and spt4 deletion strains,
deadenylation rate of GAL1 mRNA was calculated to be about 2.1 nucleotides per
minutes (Table 4), and the oligo (A) tail form of GAL1 mRNA routinely appeared in 20
to 25 minutes (Figure 5B, right panel).It should be noted that the total RNA intensity
decreased after about 20 minutes in the wild-type and spt5-242 strain (Figure 1IB, left
panel). However, we did not see an obvious reduction in the intensity of the GAL1
mRNA even after 40 minutes in spt5-4 and spt4 deletion strain (Figure 1IB, right panel),
supporting the view that the deadenylation, decapping, and 5’ to 3’ mRNA digestion of
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the GAL1 mRNA was significantly delayed in spt5-4 and spt4 background because o f the
slower rate o f deadenylation. These observations indicate that the deadenylation rate o f
GALJ mRNA can be reduced by spt5-4 and spt4 but not by spt5-242 and that SPT5/SPT4
affects mRNA turnover through their effects on mRNA deadenylation.
SPT5 is Present in The Cytoplasm
The above experiments indicated a role for SPT5 in mRNA turnover. Previous
research has shown that SPT5/SPT4 play a role in RNA metabolism that occurs in the
nucleus (Hartzog et al., 1998; Lindstrom et al., 2003; Pei and Shuman, 2002; Swanson et
al., 1991a; Wada et al., 1998a; Wen and Shatkin, 1999; Wu-Baer et al., 1998). CCR4NOT components, in contrast, are found in both nuclear and cytoplasmic compartments
(Tucker et al., 2002; Tucker et al., 2001) and the primary function o f CCR4 in mRNA
degradation is presumed to be cytoplasmic. If SPT5 is involved in mRNA degradation
through its interaction with CCR4-NOT components, it might be expected that some
SPT5 should be present in the cytoplasm. To reexamine the subcellular localization of
SPT5, we used a strain with a Flag tag on the C-terminus o f the chromosomal SPT5 gene,
and an immunofluorescence assay was conducted using a FITC-conjugated secondary
antibody. As shown in Figure 12, the majority o f SPT5 is localized to the nucleus,
consistent with previous observations. Careful analysis o f the data indicates, however,
that some SPT5 is present in the cytoplasm (Figure 12). These results support the
hypothesis that SPT5 is involved in mRNA degradation through its interaction in the
cytoplasm with CCR4. These data do not exclude the possible role that SPT5 may still
regulate CCR4 deadenylase activity in the nucleus, especially as CCR4 has been shown
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to play roles in transcriptional initiation and elongation (Badarinarayana et al., 2000;
Deluen et al., 2002; Denis et al., 2001; Lemaire and Collart, 2000).

Figure 12

WT

SPT5-FLAG

MERGE

Figure 12. SPT5 is localized to both the nucleus and the cytoplasm.
Strains expressing Flag-Tagged SPT5 (FY1642) and wild-type control (FY1639) were
incubated with anti-Flag antibody and stained with FITC-conjugated anti-mouse antibody
and DAPI as indicated.
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Discussion
The SPT4/SPT5 complex has been shown to be important in multiple steps of
mRNA processing (Hartzog et al., 1998; Lindstrom et al., 2003; Pei and Shuman, 2002;
Swanson et al., 1991a; Wen and Shatkin, 1999; Wu-Baer et al., 1998; Yamaguchi et al.,
1999b). We show herein that this complex in yeast physically associates in vivo with
components of the CCR4-NOT complex. The CCR4-NOT complex, in turn, has known
or suggested roles in transcriptional initiation, elongation, and mRNA degradation (Chen
et al., 2002; Daugeron et al., 2001; Denis, 1984; Denis et al., 2001; Tucker et al., 2002;
Tucker et al., 2001; Viswanathan et al., 2003). Several pieces o f evidence provided by
Yueh-Chin Chiang support a close physical association o f SPT5 with components o f the
CCR4-NOT complex. First, in the two-hybrid assay SPT5 displayed interactions with
CCR4-NOT complex components NOT1, NOT2, CCR4, CAF40, and CAF130. Second,
each o f these two-hybrid interactions was shown to occur by co-immunoprecipitation
analysis. Third, SPT5 and CCR4, at their physiological concentration, were found to
specifically co-immunoprecipitate. Fourth, the CAF1 protein when overexpressed
interfered with SPT5-CCR4 interactions. Moreover, deleting CAF1 revealed additional
SPT5 contacts to the CCR4-NOT components, NOT1, NOT4, and CAF40 when they
were expressed at their physiological concentrations. These results clearly indicate a
close proximity in the cell of CCR4-NOT components with SPT5. This physical
proximity agrees with various experiments establishing that the components o f CCR4NOT complex and SPT5 protein can be present both in the nucleus and in the cytoplasm
(Collart and Struhl, 1993; Swanson et al., 1991a; Tucker et al., 2002; Tucker et al., 2001).
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In addition to the physical interaction between CCR4-NOT proteins and SPT5,
several pieces of evidence also suggest that SPT5 functionally interacts with CCR4-NOT
complex. First, genetic assay showed that spt5-4, spt5-25, spt5-8, and spt5-194 were
found to suppress defects in ccr4 (C. L. Denis, pers. Comm.). Second, spt5-4, spt5-194,
and spt4 can slow down mRNA degradation rate. These alleles when combined with
ccr4, however, did not further reduce the rate of mRNA decay. Third, these alleles which
slow down mRNA decay also reduced the rate o f mRNA deadenylation but had no effect
on mRNA decapping and 5’ to 3’ digestion. The sptS alleles that did not affect mRNA
decay, however, also had no effect on mRNA deadenylation. Fourth, SPT5 is also present
in the cytoplasm. Finally, in vitro deadenylase activity assay showed that SPT5 can
partially inhibit CCR4 deadenylase activity but SPT5 alone does not have deadenylase
activity.
It should be noted that the spt5-4 and spt5-194 proteins are defective for binding
SPT4 (G. Hartzog, pers. Comm.). Other spt5 alleles not defective for binding SPT4, such
as spt5-242 or spt5-25, has no effect on mRNA degradation and deadenylation, indicating
that SPT5/SPT4 interaction is important in its effect on mRNA degradation and
deadenylation. There are two models explaining how SPT5/SPT4 could affect the mRNA
deadenylation rate. First, the interaction between SPT4 and SPT5 can interfere with the
negative effect o f SPT5 on CCR4 deadenylase activity. Therefore, after the SPT5/SPT4
complex is disrupted either by mutating the SPTS gene (spt5-4, and sptS-194) or by
deleting the SPT4 gene, SPT5 will be released to inhibit CCR4 deadenylase activity.
Another model is that the SPT5/SPT4 interaction can affect SPT5 localization. SPT4 may
retain SPT5 in the nucleus by binding SPT5. Disrupting interaction between SPT5 and
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SPT4 will result in more SPT5 present in the cytoplasm, and therefore, result in inhibition
of CCR4 deadenylase activity. We observed that SPT4 is more predominantly localized
in the nucleus as compared to SPT5. However, deleting SPT4 did not appear to affect the
subcellular localization of SPT5 (data not shown).
Although spt5-4, spt5-194 and spt4 can reduce the rate o f GAL1 mRNA
deadenylation, these effects are not as significant as that observed with ccr4. In addition,
these alleles did not display as prominent defect the deadenylation end point as did ccr4
and cafl strains (Figure 11A; Tucker et al., 2001). Since these spt5 alleles and spt4 have
similar effect on reducing the rate of mRNA degradation as ccr4 did, but less effects on
mRNA deadenylation, SPT5/SPT4 might also be affecting mRNA degradation through
other mechanisms. The requirement o f deadenylation before decapping indicates that the
poly (A) tail also acts as an inhibitor o f decapping(Decker and Parker, 1993; Muhlrad et
al., 1994; Muhlrad et al., 1995). Several observations suggest that the ability o f the poly
(A) tail to inhibit decapping is mediated through the poly (A) binding protein (PAB1)
(Caponigro and Parker, 1995; Morrissey et al., 1999; Sachs et al., 1987). ccr4 can affect
not only the rate of deadenylation, but also the extent of deadenylation, therefore
inhibiting the subsequent decapping and 5’ to 3’ deadenylation (Tucker et al., 2001). We
observed that, in spt5-4 and spt4 strains, the poly (A) tail is degraded to an oligo (A) tail
length o f approximately 6-10A’s by around 20-25 minutes, whereas obvious GAL1
mRNA intensity reduction was not observed even after 40 minutes (Figure 5B, right
panel). This observation indicates that spt5-4 and spt4 not only slow the rate of
deadenylation, but they might also block the poly (A) tail mediated decapping signal.
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CHAPTER m

OTHER RESULTS

Elongation Results
ccr4 Enhances the Ability of RNA pol II to Form the Full-length lacZ mRNA
Genetic analyses have implicated the CCR4-NOT complex in playing possible
roles in transcription elongation (Denis et al 2001). To investigate whether CCR4
affected elongation in vivo, an SI nuclease protection assay was employed to analyze the
ability of RNA pol II to form full-length lacZ mRNA in presence of a ccr4 deletion. We
found, as shown in Figure 13, that in contract to other elongation factor defects, ccr4
displayed enhanced full-length lacZ 3' RNA formation (one and a half to two-fold effects
for ccr4, Figure 13A, lanes 1 and 2, and Figure 13B, lanes 1 and 2). A cafl deletion gave
similar results to ccr4 (Figure 13A, lane 3).
To determine whether ccr4 affects RNA pol II transcript through lacZ gene by
affecting cryptic poly (A) sites usage within lacZ gene, both total RNA and poly (A)
RNA were used to conduct SI nuclease protection assay (Figure 13B). My results
showed that a ccr4 deletion displayed similar effects on full-length lacZ RNA formation
when both total and poly (A) RNA were used (1.9-fold effects for total RNA, Figure 13B,
lanes 1 and 2; 1.8-fold effects for poly (A) RNA, Figure 13B, lanes 3 and 4). This result
suggested that the ccr4 deletion may enhance the ability of RNA pol II to form fulllength lacZ RNA by affecting lacZ cryptic poly (A) sites usage.
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Figure 13
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Figure 13. ccr4 and cafl alleles enhance full-length lacZ mRNA formation.
(A) SI nuclease protection analysis of total RNA extracted from the WT strain EGY188
(lane 1), ccr4 strain EGY188-la (lane 2) and cafl strain EGY188-cl (lane 3). SI
nuclease protection assays, growth conditions, and calculations were conducted as
described in Figure 1.
(B) Both total RNA (lane 1 and 2) and poly (A) RNA (lane 3 and 4) were extracted from
WT strain EGY188 (lane 1 and 3) and ccr4 strain EGY188-la (lane 2 and 4) and used for
SI nuclease protection assays. SI nuclease protection assays, growth conditions, and
calculations were conducted as described in Figure 1.
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ccr4 Does Not Enhance the Ability of RNA pol II to Form Full-length lacZ RNA By
Suppressing Transcriptional Termination/cleavage.
ccr4 may affect lacZ cryptic poly (A) sites usage directly or indirectly. It can
indirectly reduce cryptic poly (A) site usage through its effect on elongation. It can also
reduce cryptic poly (A) site usage by suppressing transcription termination/cleavage. To
determine which possibility is the case, the effect of ccr4 on transcriptional
termination/cleavage was examined. SI nuclease protection assays were carried out in
strains carrying plasmid pGCYCl which expresses Gall-CYCl. Probes against the CYC1
coding region (+139) and against a site that was 350 bp downstream o f the CYC1
polyadenylation site (+853) were used to examine the abundance o f the different CYC1
transcript species. In the wild-type strain, the normal CYC1 polyadenylation site (+503)
was used and no CYC1 transcript beyond +853 was detected (Figure 14, lanes 1,5 and 8).
With rnal4 and rnalS mutations which can affect transcription termination (Birse et al
1998), normal transcription termination was suppressed and more long CYC1 transcripts
beyond +853 were formed after switching growth from the permissive (25°C, Figure 14,
lanes 6 and 7) to the restrictive condition (37°C, Figure 14, lanes 3 and 4). The papl
mutation, which has no effect on transcription termination (Figure 14, lane 2), and the
ccr4 deletion can not suppress transcription termination (Figure 14, lane 9). These results
suggest that ccr4 does not enhance the ability o f RNA pol II to form full-length lacZ
RNA by suppressing transcriptional termination.
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Figure 14
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Figure 14. ccr4 does not suppress transcriptional termination o f the CYC1 gene.
SI nuclease protection analysis of total RNA extracted from WT strain W303 (lane 1 and
5) and EGY188 (lane 8),pap 1-5 strain LM98 (lane 2), rnal4-l strain LM91 (lane 3 and
6), rnal5-l strain LM88 (lane 4 and 7) and ccr4 strain EGY188-la (lane 9) containing
plasmid pGCYCl which expresses Gal-CYCl. For lanes 1 to 7, strains were pregrown in
4% glucose medium at 25°C for 20 hr, and then shifted to 2% galactose/2% raffmose at
nonpermissive temperature (37°C) for 4 hr (lanes 1 to 4) or at permissive temperature
(25°C) for 4 hr (lanes 5-7). For lanes 8 and 9, strains were pregrown in 4% glucose
medium at 30°C for 20 hr, and then shifted to 2% galactose/2% raffmose at 30°C for 4 hr.
Probe 1 is directed against the CYC1 coding region (+139) and probe 2 is directed against
a region 350 bp downstream o f the CYC1 polyadenylation site (+853).

75
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

The Effect of ccr4 on full-length lacZ mRNA Formation Is Not Due To Increased
mRNA 3' End Degradation.
Since both CCR4 and CAF1 have been shown to be part o f the cytoplasmic
mRNA deadenylase complex (Tucker et al 2001), it was possible that the above effects
on full-length lacZ 3’ RNA formation were resulting from differential effects on the
degradation o f the 3’ and 5’ ends o f lacZ mRNA. To address this possibility we utilized
the GALl-lacZ reporter to determine the rate o f degradation o f the 5' and 3' ends o f the
lacZ mRNA following the shutting off o f GALl-lacZ transcription by growth on glucosecontaining medium. As expected, ccr4 decreased the degradation rates of lacZ mRNA by
2- to 3-fold (Figure 15,6 min. half life for WT and 16 min. half life for ccr4), but it did
so for both 5’ and 3’ ends of the lacZ mRNA (Figure 15). These results indicate that the
enhanced ability to form full-length lacZ mRNA by ccr4 results from an enhanced ability
to elongate through the lacZ gene.
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Figure 15
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Figure 15. ccr4 decreases lacZ mRNA decay rate but does not decrease degradation of
the 3' end of the lacZ mRNA relative to that of the 5' end.
Wild-type and ccr4 strains (see Table 1) transformed with the GALl-lacZ plasmid were
pregrown on 2% galactose/2% raffmose prior to shifting to medium containing 4%
glucose at zero time and taking o f RNA samples at the times indicated. The 5' lacZ probe
corresponded to sequences 0.5 kb downstream of the initiation site whereas the 3' lacZ
probe was located 2.9 kb downstream. Hie ACT! RNA was used to standardize loadings
for RNA samples at the different time points indicated.
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While rvb2-4 And rpb2-10 Alleles Can Suppress a ccr4 Defect ccr4 And spt5-4 Have
a Mixed Effect On Transcription Elongation.
To further investigate the role o f CCR4 on transcription elongation, we examined
the effect of ccr4 on lacZ mRNA elongation in rpb2 and sptS backgrounds.
As previously shown, rpb2-4, rpb2-10 and spt5-4 reduced the ability o f RNA pol
II to form full-length lacZ RNA (Figure 16, lanes 2 ,3 and 9) while ccr4 increased it
(Figure 16, lane 4 and 8). While ccr4 caused a 2.2-fold increase in full-length lacZ
mRNA (Figure 16, lane 4 compared to lane 1), it allowed only 1.4- and 1.6-fold effect,
respectively, in full-length lacZ mRNA formation in rpb2-4 and rpb2-10 backgrounds
(Figure 16, lanes 5 and 6 compared to lanes 2 and 3). This result indicates that rpb2-4 and
rpb2-10 alleles can partially suppress the effect o f ccr4 on lacZ elongation and that CCR4
acts upstream o f RPB2 to affect elongation. In contrast, the ccr4 allele, while causing a
1.7-fold increase in full-length lacZ formation in a wild-type background (Figure 16 lane
8 compared to lane7), caused a 3.8-fold increase in an spt5-4 background (Figure 16, lane
10 compared to lane 9). In addition, spt5-4 still has an effect on lacZ elongation in the
ccr4 background (Figure 16, lane 10 compared to lane 8), although not as much as it does
in wild-type background (Figure 16, lane 9 compared to lane 7). This mixed effect of
ccr4 and spt5-4 alleles on lacZ elongation indicates that CCR4 may act downstream or in
conjunction with SPT5 to affect elongation.
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Figure 16. ccr4 specifically suppresses the spt5-4 defect on elongation but not that of
rpb2-4 or rpb2-10.
S I nuclease protection analysis o f total RNA extracted from ccr4 strain Z96-la (lane2),
rpb2-4 strain Z100 (lane 3), rpb2-4 ccr4 strain ZlOO-la (lane4), rpb2-10 strain Z106
(lane 5), rpb2-10 ccr4 strain Z106-la (lane 6) and the isogenic WT strain Z96 (lanelO),
ccr4 strain FY1642-la (lane 8), spt5-4 strain FY1668-uH (lane 9), spt5-4 ccr4 strain
FY1668-uH-la (lane 10) and die isogenic WT strain FY1642 (lane 7). SI nuclease
protection assays, growth conditions, and calculations were conducted as described in
Figure 1.
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Growth Condition of the Yeast Strain can Affect Full-length Formation of the lacZ
RNA.
Several spt5 alleles have been shown to be cold sensitive (Hartzog et al., 1998). It
has also been shown that an Artificial Arrest (ARTAR) site does not appear to function
under optimal growth condition (Kulish and Struhl, 2001). These data indicate that the
growth condition o f the cells might affect RNA pol II transcript through the genes.
Therefore, the effect of different growth conditions on full-length lacZ mRNA formation
was examined in wild-type and elongation defective strains background. The yeast were
grown in the medium containing 4% glucose, 2% galactose/raffinose, 2% ethanol, or 4%
glucose with 200ug/ml 6-azauracil respectively. In the wild-type strain background, as
shown in Figure 17, less optimal growth condition (galactose/raffinose or ethanol) can
increase full-length lacZ RNA formation (Figure 17A, lanes 2,3, compared to lane 1;
17B, lane 2, compared to lane 1), but the drug 6-AU has no effect on full-length lacZ
RNA formation. In contrast, in the spt5-4 strain background, although the ability o f RNA
pol II to form full-length lacZ RNA was decreased compared to wild-type, the growth
conditions have no significant effect on full-length lacZ formation (Figure 17A, lanes 5 to
8). The exact same result was obtained in an rpb2-4 strain background (Figure 17B, lanes
3 and 4).
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Figure 17. The effect of the growth
condition of cells on full-length lacZ RNA
formation
SI nuclease protection analysis o f total
RNA extracted from spt5-4 strain FY1668uH (A, lanes 5 to 8) and the isogenic WT
strain FY1642 (A, lanes 1 to 4); rpb2-4
strain Z100 (B, lanes 3 and 4) and the
isogenic WT strain Z96 (B, lanes 1 and 2).
The strains were pregrown over night in the
medium containing 4% glucose prior to
shifting to growth condition as indicated in
the Figure for 4 hours. SI nuclease
protection assays and calculations were
conducted as described in Figure 1.
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Degradation Results
SPT5 Can Affect MFA2 dG RNA Decay
We showed in Chapter II that SPT5 can affect the degradation rate o f ADH2 and
GAL1 mRNA probably through its physical and functional interaction with CCR4. The
effect of CCR4 on MFA2pG RNA degradation has been thoroughly investigated
previously (Tucker et al., 2001). To further confirm the functional connection between
CCR4 and SPT5, the effect o f SPT5 on MFA2pG RNA decay was examined.
I examined the decay rate of MFA2pG RNA in wild-type and spt5-4 strain
backgrounds. MFA2pG is under the control of GAL1 promoter, allowing the measure o f
its decay rate by adding glucose to repress transcription. I observed that the MFA2pG
RNA was stabilized about 2-fold in the spt5-4 strain compared to wild-type (Figure 18).
spt5-4 also reduced the degradation rate o f ADH2 and GAL1 mRNA as shown in Chapter
II, indicating that SPT5 is required for the turnover of a number o f yeast mRNA.
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Figure 18
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Figure 18. spt5-4 can reduce the decay rate o f the MFA2pG mRNA.
Transcriptional shutoff analysis of MFA2pG mRNA from wild-type (FY1642) and spt5-4
(FY1668-uH) strains. The full-length (FL) mRNA and decay fragment (Frag.) are
indicated at die left. Time points are minutes after the addition o f glucose.

SPT5/SPT4. Similar As CCR4/CAF1. Can Affect the Endpoint of MFA2dG mRNA
Deadenylation
It has been shown previously that not only can CCR4, as major cytoplasmic
deadenylase, affect MFA2pG mRNA deadenylation rate, it also affect the length of poly
(A) tail o f MFA2pG mRNA at late time point (Tucker et al., 2001). Therefore, to
understand the relationship between CCR4 and SPT5, the effect of SPT5/SPT4 on the
endpoint of MFA2pG mRNA deadenylation was examined.
The distribution of poly (A) tail length was measured for MFA2pG under steady
state conditions from wild-type, ccr4A, sptS and spt4 alleles. As shown in Figure 19, if
samples were first treated with RNase H and oligo (dT), the poly (A) tail o f MFA2pG
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mRNA from different strains will be removed. The remaining transcripts have the same
length (Figure 19, lanes 1 to 6). Wild-type MFA2pG mRNA has a steady state poly (A)
distribution from 75 to about 10-12 adenosine residues (Figure 19, lane 7; Tucker et al.,
2001). In ccr4A strain, MFA2pG mRNA has the longest poly (A) tail (Figure 19, lane 8).
spt5-242 allele, which has no effect on ADH2 mRNA degradation and GAL1 mRNA
deadenylation, did not affect on poly (A) distribution (Figure 19, lane 9). In contrast, in
the spt5-4, spt5-194, and spt4A strains, in which ADH2 mRNA decay rate and GAL1
mRNA deadenylation rate were reduced, the poly (A) tail of MFA2pG is slightly longer
than observed in wild-type strain, but is shorter than observed in ccr4A strain (Figure 19,
lanes 10 to 12, compared to lanes 6 and 7).
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Figure 19

MFA2pG

Figure 19. SPT5 and SPT4 can affect MFA2pG mRNA deadenylation endpoint.
The deadenylation end point for MFA2pG transcript was measured in the wild type
(FY1642), ccr4A (FY1642-la), spt5-242 (FY1635), spt5-4 (FY1668-uH), spt4A
(GHY180), and spt5-194 (FY300) strains. The strains were pregrown over night in the
medium containing 4% glucose prior to shifting to 2% galactose for 4 hours. Steady state
mRNA were detected by Northern analysis with or without removal of poly (A) tails with
RNase H and oligo (dT) as indicated in the Figure.
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GENERAL DISCUSSION

The Regulation of Gene Expression Is a Continuous Process
Gene expression is a pathway with multiple steps. The regulation o f gene
expression can occur at each step during this process. The different steps in this pathway
have previously been treated and studied as independent events. In recent years, a
growing number of genetic studies have revealed functional links between the protein
factors that carry out the different steps in the gene expression pathway. Many factors
have also been found to perform their regulatory function in more than one steps in this
process. SPT5 has been identified as a protein that can regulate transcriptional initiation,
elongation, and pre-mRNA processing (Andrulis et al., 2002; Hartzog et al., 1998; Kim et
al., 1999; Lindstrom et al., 2003; Wen and Shatkin, 1999; Yamaguchi et al., 1999b). In
Chapter I, we further confirmed the role o f SPT5 in the regulation o f transcriptional
elongation. In addition, out results in Chapter II also suggested that SPT5 can regulate
gene expression by affecting mRNA stability, possiblely through its physical and
functional interaction with CCR4-NOT complex,confirming multiple roles for SPT5 in
the regulation of gene expression. Similarly, the CCR4-NOT complex acts at several
steps in the gene expression pathway, including transcriptional initiation, elongation, and
mRNA degradation (Badarinarayana et al., 2000; Chen et al., 2002; Daugeron et al.,
2001; Deluen et al., 2002; Denis, 1984; Denis et al., 2001; Lemaire and Collart, 2000;
Liu et al., 1998; Sakai et al., 1992; Tucker et al., 2002; Tucker et al., 2001). In Chapter
m , we further confirmed that CCR4 can affect transcriptional elongation in vivo.
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Moreover, rpb2 mutations can suppress this effect. Combined with the data that CCR4
can associate with RNA pol II (Chang et al., 1999), these results suggest that CCR4
might affect transcriptional elongation through its interaction with RNA pol n.
It has also been shown that the regulation of one step o f gene expression can
subsequently affect another one or more steps o f this process. For example, pre-mRNA
splicing can promote transcription elongation and is required for efficient export o f the
resulting mRNA in to the cytoplasm (Reed and Hurt, 2002). In Chapter I, we also showed
that increased pausing can enhance upstream poly (A) site utilization, indicating a
connection between transcriptional termination/cleavage and elongation. Moreover,
elongation defects can increase upstream poly (A) site choice at 3’ end of GAL1, and
therefore, enhance shorter but more stable GAL1 mRNA formation, suggesting a
connection between the transcriptional elongation and termination/cleavage which
happened in the nucleus and the mRNA degradation in the cytoplasm.

SPTS Needs SPT4 To Perform Its Function
Recent studies have demonstrated roles for SPT5 and SPT4, as a complex, in the
regulation o f transcriptional elongation both in yeast and in humans (Hartzog et al., 1998;
Kim et al., 1999; Wada et al., 1998; Yamaguchi et al., 1999a; Yamaguchi et al., 1999c).
Although it has been shown that an spt4 deletion has similar phenotypes as some spt5
defects (Hartzog et al., 1998) and SPT4 has a positive role in transcriptional elongation
(Rondon et al., 2003), SPT5 has been shown to contact with the RNA pol II and is
thought to play the major role in regulation of transcriptional elongation. The importance
of SPT4 in this process is not clear. In Chapter I, we examined the effect o f some spt5
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alleles and spt4 deletion on the full-length lacZ RNA formation. It was shown that spt5-4
and spt4 deletion can reduce full-length lacZ RNA formation. Interestingly, the spt5-4
protein is defective for binding SPT4 (G. Hartzog, pers. comm.), indicating that SPT5
requires SPT4 to play a role in transcriptional elongation. In addition, we also showed in
Chapter II that the spt5-4, spt5-194, and spt4 alleles slowed the rate of degradation of
ADH2 mRNA and the rate of deadenylation o f GAL1 mRNA. spt5-194 proteins is also
defective for binding SPT4 (G. Hartzog, pers. comm.). Other spt5 alleles not defective for
binding SPT4 had no effect on ADH2 mRNA degradation and GAL1 mRNA
deadenylation. These results suggest that the interaction between SPT5 and SPT4 is also
required for their roles in regulation o f mRNA degradation. Therefore, SPT4 is
indispensable for SPT5 to perform its function in the regulation of gene expression.

The Interaction Between The CCR4-NOT Complex And The SPT5/SPT4 Complex
Can Affect Their Roles In The Regulation of Gene Expression
Our lab showed that SPT5 can interact with CCR4-NOT complex and inhibit
CCR4 deadenylase activity. While CCR4 is present everywhere in the cell, most of SPT5
is localized to the nucleus. Therefore, an important function o f SPT5 might be to inhibit
CCR4 deadenylase activity in the nucleus so that the mature mRNA in the nucleus will
not be deadenylated before export to the cytoplasm and translate into protein. Both CCR4
and SPT5 have been shown to bind with the RNA Pol IICTD (Chang et al., 1999;
Lindstrom and Hartzog, 2001) and we also showed in Chapter IE that CCR4 and SPT5
have a mixed effect on full-length lacZ RNA formation, indicating that SPT5 can affect
the function o f CCR4 in regulation of transcriptional elongation and inhibit the CCR4
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deadenylase activity in nucleus. CCR4, in turn, can also affect the function o f SPT5 in
transcription.
Chromatin immunoprecipitation assay showed that SPT5 can associate with both
promoters and open reading frames of transcribed genes in vivo (Pokholok et al., 2002).
SPT5/SPT4 has also been found to interact with the mRNA capping enzyme and cap
methyltransferase (Lindstrom et al., 2003; Wen and Shatkin, 1999). Moreover, SPT5 has
been found to associate with RNA processing exosome in the nucleus (Andrulis et al.,
2002). It might be possible that SPT5 associates with RNA directly or by binding with
other RNA binding proteins in the nucleus and is exported to the cytoplasm together with
mature RNA. Therefore, the stability of mRNA can be regulated by SPT5 through its
interaction with and inhibition of CCR4 deadenylase activity.
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